syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	45.796424313211524
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	43.222966696875915
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.516150233723735
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
LAFORA DISEASE	0.7730060599999999	29.000211478538862
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.08380087522927
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607864
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.676035614	25.362253658171667
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59421851	22.292790892819472
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	20.06401605811282
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.518324164	19.445527206393262
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.51073636	19.160862011585213
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.504116984	18.912528507115706
CREST SYNDROME	0.5	18.758075116861868
PAROXYSMAL HEMICRANIA	0.5	18.758075116861868
INHALATIONAL ANTHRAX	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	16.305074280664396
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064626
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.417300504	15.655508400672632
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062604
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39053901	14.651520171289736
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3638483	13.650187485084986
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
CENTRALOPATHIC EPILEPSY	0.3547009	13.30701225243702
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.346849954	13.012474982824168
COG4-CDG	0.34456710399999996	12.926831239263109
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.344263504	12.915441336052153
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.852742695070942
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31714300999999995	11.897984808735346
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.255629954	9.590251758503888
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254116984	9.53349094868477
PALLISTER-HALL SYNDROME	0.250545554	9.399504644255543
DYSTONIA 6, TORSION	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951174
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.23608447300000002	8.856980556917495
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	8.475991933577506
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22536641400000001	8.45488024525958
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.307456256075035
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.21591691999999998	8.10037160872291
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21068855000000003	7.904223294325416
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.20704225	7.767428155728188
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206135503	7.7334104990522095
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002376
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.503230046744748
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.503230046744748
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.503230046744748
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	7.105249346027849
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266897
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266897
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17747180399999998	6.6580588611139735
UNILATERAL POLYMICROGYRIA	0.17504395	6.566975125704426
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.158505434608279
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16341620399999998	6.130746859888845
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15970406399999998	5.99148165796023
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.727283548976788
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155532
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.440824707026065
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.143402554	5.37991175976368
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356097
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.131794948577926
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.127564073	4.785712927093702
NIEMANN-PICK DISEASE, TYPE C2	0.127564073	4.785712927093702
LATHOSTEROLOSIS	0.12717273899999998	4.7710315819581375
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.1271692	4.770898812302462
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.1271692	4.770898812302462
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.127018519	4.765245841269093
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12107156999999999	4.542139209152799
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656996
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427327
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11601042	4.35226434539739
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.1152645	4.32428029861505
BILATERAL POLYMICROGYRIA	0.10682996399999999	4.0078489788872975
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
AICARDI SYNDROME; AIC	0.1036867	3.8899258144390427
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.815490020760312
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.10152670000000001	3.8088909299341998
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.100563054	3.7727386418260727
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572894
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.6913586087390793
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.6913586087390793
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.681154065810906
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.681154065810906
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.09446700000000001	3.5440381641291805
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955697
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.08299461	3.11363825734931
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08051991	3.020797040365914
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07847085000000001	2.9439241975680006
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.906325661868364
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868364
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437547
WILLIAMS SYNDROME	0.07663135000000001	2.874913239213066
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07647713	2.869127498524021
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.7809878054879147
NIEMANN-PICK DISEASE TYPE B	0.0741225	2.780790845699187
GRISCELLI SYNDROME	0.07399267300000001	2.7759202364627944
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.073645054	2.7628789098346975
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07305992000000001	2.740926934783838
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07294859999999999	2.736750636939819
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.07197415400000001	2.700193174409169
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.6835377294483056
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	2.6797260885845593
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.6797260885845593
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.6797260885845593
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	2.6797260885845593
STIFF SKIN SYNDROME	0.07142860000000001	2.6797260885845593
ADULT-ONSET STILL DISEASE	0.07142860000000001	2.6797260885845593
KENNEDY DISEASE	0.07142860000000001	2.6797260885845593
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.6797260885845593
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	2.6797260885845593
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.067601994	2.536166563003291
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067378873	2.5277959220469923
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.521545018611199
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.066952723	2.5118084146248907
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.50107793278659
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.50107793278659
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06659940399999999	2.498553245940461
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.4870168796789907
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06565660000000001	2.463182869435506
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.348430344908104
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.06247905399999999	2.3439735763249376
PONTINE TEGMENTAL CAP DYSPLASIA	0.062079673	2.328990338728443
WHITE-SUTTON SYNDROME; WHSUS	0.061841784	2.320065659265493
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.061387573	2.3030254111516832
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.060846154	2.2827134546082903
GIANT CELL ARTERITIS	0.0603006	2.2622463687836816
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.06028407300000001	2.2616263393687692
DYSTONIA-APHONIA SYNDROME	0.059910473	2.2476103056414494
LYSINURIC PROTEIN INTOLERANCE	0.059889200000000004	2.246812224577528
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.059369054	2.2272983490980574
ADNP SYNDROME	0.059364919	2.227143219816841
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.2182185403538903
GITELMAN SYNDROME	0.059127030000000004	2.2182185403538903
CLEFT LIP AND ALVEOLUS	0.0588235	2.206831263273448
MYASTHENIA GRAVIS; MG	0.0588235	2.206831263273448
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	2.206831263273448
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0588235	2.206831263273448
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.0588235	2.206831263273448
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0588235	2.206831263273448
OROMANDIBULAR DYSTONIA	0.0588235	2.206831263273448
CITRULLINEMIA TYPE II	0.058806973000000005	2.206211233858536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.058323464	2.1880718375751775
ALSTROM SYNDROME; ALMS	0.058265554000000004	2.1858992773151433
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
FISH-EYE DISEASE	0.05772	2.165432191490534
DYSBETALIPOPROTEINEMIA	0.05772	2.165432191490534
ATHEROSCLEROSIS SUSCEPTIBILITY	0.05772	2.165432191490534
NIEMANN-PICK DISEASE, TYPE B	0.05772	2.165432191490534
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.05772	2.165432191490534
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.05772	2.165432191490534
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.05772	2.165432191490534
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.05772	2.165432191490534
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.05161315	1.9363266894357183
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.05161315	1.9363266894357183
CHROMOSOME 17Q12 DELETION SYNDROME	0.05138561999999999	1.9277906397730389
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
ALG13-CDG	0.049802	1.8683793139399094
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8411746276625256
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.049064204	1.8407000483620692
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510333
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.048531743999999995	1.8207241990086203
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.047619	1.7864815579796907
APOLIPOPROTEIN A-I DEFICIENCY	0.047619	1.7864815579796907
TANGIER DISEASE; TGD	0.047619	1.7864815579796907
HYPERLIPOPROTEINEMIA, TYPE V	0.047619	1.7864815579796907
FISH-EYE DISEASE	0.047619	1.7864815579796907
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04745448299999999	1.7803095134916889
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.7173038028208167
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.044202130000000006	1.6582937497305872
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04407925	1.6536837651898668
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.043631803999999996	1.6368973138323881
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853604
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042578484	1.5973808024682024
COG2-CDG	0.04221225399999999	1.5836412627681054
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5836412627681054
19P13.3 MICRODUPLICATION SYNDROME	0.04217420399999999	1.5822137732517123
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.04199877399999999	1.5756323150162101
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04141455399999999	1.553714629726664
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.548334813783148
ACROCEPHALOPOLYDACTYLY	0.04009282	1.5041282584136437
SHPRINTZEN OMPHALOCELE SYNDROME	0.04009282	1.5041282584136437
SLC35A2-CDG	0.039845903999999994	1.4948649206625335
16P13.11 MICRODELETION SYNDROME	0.039751754	1.4913327751180285
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379245
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.4743978348379245
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03923768	1.472046697702777
TRICHOTHIODYSTROPHY	0.039213874	1.4711535882303133
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.038937033999999995	1.460767617199609
CHROMOSOME 1P36 DELETION SYNDROME	0.038547823	1.4461659188509912
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
MYOCLONUS AND ATAXIA	0.0385141	1.4449007617166596
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143656
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143656
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4429274122143656
MAL DE MELEDA	0.0384615	1.4429274122143656
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4429274122143656
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143656
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143656
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143656
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143656
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143656
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0384615	1.4429274122143656
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143656
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143656
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143656
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143656
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143656
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143656
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.037878800000000004	1.4210667514731747
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0376773	1.4135072472010792
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.037640679999999996	1.4121334057795203
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310347
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
CHRISTIANSON SYNDROME	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.389485656206426
CANAVAN DISEASE	0.037037	1.389485656206426
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.389485656206426
ALPERS-HUTTENLOCHER SYNDROME	0.036842704000000004	1.3821964182806146
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.036784003999999995	1.3799942202618947
PEHO SYNDROME	0.03660417399999999	1.373247690965364
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3726183575451936
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715000000001	1.3617293324560058
DOORS SYNDROME	0.03624612399999999	1.3598150333741792
PMM2-CDG	0.036134142999999994	1.3556139373548568
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03605862	1.3527806051407554
AICARDI SYNDROME	0.03582953	1.3441860302837116
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.035543054000000004	1.3334385536293556
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.03477883	1.304767811233138
3P25.3 MICRODELETION SYNDROME	0.03433533	1.2881293986044815
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.033606343999999996	1.2607806503102001
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033369719	1.2519033912611455
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790924
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.032487842999999995	1.2188187987576298
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
EPILEPSY, PYRIDOXINE-DEPENDENT	0.032129244	1.205365544799967
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
15Q13.3 MICRODELETION SYNDROME	0.030496093000000002	1.1440960065296109
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581094
MENINGIOMA	0.0292549	1.0975312234725647
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869403
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0625832037869403
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869403
MENKES DISEASE	0.028319219000000003	1.0624280745057237
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0421161179623313
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623313
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623313
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623313
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0421161179623313
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623313
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	1.0421161179623313
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623313
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623313
CLEFT CHIN	0.027777800000000002	1.0421161179623313
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623313
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623313
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623313
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623313
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623313
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623313
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623313
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623313
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.0421161179623313
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623313
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623313
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623313
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623313
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623313
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623313
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.027777800000000002	1.0421161179623313
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623313
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0421161179623313
19P13.13 MICRODELETION SYNDROME	0.027614793	1.0360007228611825
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.034260948910244
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027027	1.0139489923668514
HAREL-YOON SYNDROME; HAYOS	0.026159503999999997	0.9814038821036968
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026124354	0.9800851894229816
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.025983473	0.9747998766619044
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.025512959999999998	0.9571480402669842
TETRASOMY 5P	0.025445593	0.9546206897741891
8Q24.3 MICRODELETION SYNDROME	0.025445593	0.9546206897741891
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.025445593	0.9546206897741891
CK SYNDROME	0.025445593	0.9546206897741891
GABRIELE-DE VRIES SYNDROME; GADEVS	0.025442054	0.9544879201185118
LAMB-SHAFFER SYNDROME	0.024904173999999998	0.9343087332307966
COHEN-GIBSON SYNDROME; COGIS	0.024904173999999998	0.9343087332307966
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361381
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024358619999999997	0.9138416474061877
17Q23.1Q23.2 MICRODELETION SYNDROME	0.024358619999999997	0.9138416474061877
KAGAMI-OGATA SYNDROME	0.023814273	0.893419843574911
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.023814273	0.893419843574911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.023814273	0.893419843574911
CHROMOSOME 5Q12 DELETION SYNDROME	0.023814273	0.893419843574911
MEND SYNDROME	0.023814273	0.893419843574911
MEND SYNDROME; MEND	0.023814273	0.893419843574911
INFANTILE LIVER FAILURE SYNDROME 1	0.023814273	0.893419843574911
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.023468314	0.8804407937562021
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8795567631920945
CHROMOSOME 15Q25 DELETION SYNDROME	0.023272854	0.8731078870315184
SWEENEY-COX SYNDROME; SWCOS	0.023272854	0.8731078870315184
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.023272854	0.8731078870315184
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.023272854	0.8731078870315184
7Q11.23 MICRODUPLICATION SYNDROME	0.023268719	0.872952757750302
EDINBURGH MALFORMATION SYNDROME	0.023268719	0.872952757750302
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.023268719	0.872952757750302
8P INVERTED DUPLICATION/DELETION SYNDROME	0.023268719	0.872952757750302
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023268719	0.872952757750302
2Q24 MICRODELETION SYNDROME	0.023268719	0.872952757750302
SALT-AND-PEPPER SYNDROME	0.022728403999999997	0.8526822190367674
SOTOS SYNDROME 2	0.0227273	0.8526408012069095
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0227273	0.8526408012069095
SPONDYLOOCULAR SYNDROME; SOS	0.0227273	0.8526408012069095
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0227273	0.8526408012069095
STICKLER SYNDROME, TYPE II	0.0227273	0.8526408012069095
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0227273	0.8526408012069095
FRONTOMETAPHYSEAL DYSPLASIA	0.0227273	0.8526408012069095
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064701
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064701
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064701
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064701
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.022277173	0.8357537690506541
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.022217949999999997	0.8335319500853622
ANGELMAN SYNDROME	0.022202303000000003	0.8329449348826554
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021873199000000003	0.820598219776136
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.021595299999999998	0.8101725191423341
X-LINKED ADRENOLEUKODYSTROPHY	0.02133178	0.8002862632327434
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997377
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021251304	0.7972671135265341
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7889376277870419
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7889376277870419
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7889376277870419
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7889376277870419
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7889376277870419
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689524
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02070575	0.7768000277019251
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0197131	0.7395596211724195
RIDDLE SYNDROME	0.019566554	0.7340617794202681
BRAIN-LUNG-THYROID SYNDROME	0.019566554	0.7340617794202681
FRAXE INTELLECTUAL DISABILITY	0.01917522	0.7193804342847041
MOEBIUS SYNDROME; MBS	0.01917522	0.7193804342847041
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.019117253999999997	0.7172057731202559
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.7158870804395406
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.019021	0.7135946935956592
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.019021	0.7135946935956592
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.019021	0.7135946935956592
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.019016264	0.7134170171081523
ADULT-ONSET DYSTONIA-PARKINSONISM	0.018630873000000003	0.6989586304534273
SPINOCEREBELLAR ATAXIA TYPE 13	0.018630873000000003	0.6989586304534273
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01853655	0.6954199946149318
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01853655	0.6954199946149318
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
AMISH INFANTILE EPILEPSY SYNDROME	0.01853655	0.6954199946149318
PERMANENT NEONATAL DIABETES MELLITUS	0.018324164	0.6874520895313921
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.018089454	0.6786466739100349
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018089454	0.6786466739100349
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.018089454	0.6786466739100349
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.018085319000000002	0.6784915446288184
INHERITED CREUTZFELDT-JAKOB DISEASE	0.018085319000000002	0.6784915446288184
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.018085319000000002	0.6784915446288184
TENORIO SYNDROME; TNORS	0.018085319000000002	0.6784915446288184
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.018085319000000002	0.6784915446288184
HUNTINGTON DISEASE-LIKE 1	0.018085319000000002	0.6784915446288184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.018032034	0.6764924965636143
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.6683721258455249
GAUCHER DISEASE	0.01777861	0.6669850037067832
MYOPATHY, DISTAL 3	0.0175439	0.6581795880854259
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0175439	0.6581795880854259
TIBIAL MUSCULAR DYSTROPHY	0.0175439	0.6581795880854259
DISTAL MYOPATHY, WELANDER TYPE	0.0175439	0.6581795880854259
DISTAL MYOPATHY, TATEYAMA TYPE	0.0175439	0.6581795880854259
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0175439	0.6581795880854259
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0175439	0.6581795880854259
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0175439	0.6581795880854259
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0175439	0.6581795880854259
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0175439	0.6581795880854259
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.0175439	0.6581795880854259
DYSTONIA 7, TORSION	0.0175439	0.6581795880854259
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0175439	0.6581795880854259
EPISODIC ATAXIA TYPE 1	0.0175439	0.6581795880854259
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0175439	0.6581795880854259
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0175439	0.6581795880854259
MACHADO-JOSEPH DISEASE TYPE 1	0.0175439	0.6581795880854259
MACHADO-JOSEPH DISEASE TYPE 2	0.0175439	0.6581795880854259
MACHADO-JOSEPH DISEASE TYPE 3	0.0175439	0.6581795880854259
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0175439	0.6581795880854259
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.0175439	0.6581795880854259
SPINOCEREBELLAR ATAXIA TYPE 3	0.0175439	0.6581795880854259
WILSON DISEASE	0.0175439	0.6581795880854259
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0175439	0.6581795880854259
PANDAS	0.0175439	0.6581795880854259
MOTION SICKNESS	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
MOSAIC TRISOMY 15	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397245
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017102273999999997	0.6416114807223072
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016948053999999997	0.6358257400332624
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6320369840211588
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016847064000000002	0.6320369840211588
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016847064000000002	0.6320369840211588
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.016799254	0.6302433368784844
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.016413353999999998	0.6157658545032904
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016413353999999998	0.6157658545032904
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6153586542086534
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6153586542086534
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.015867799999999998	0.5952987686786814
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.015841630000000002	0.594316971027065
PEHO-LIKE SYNDROME; PEHOL	0.015840373999999997	0.5942698507423713
PYRIDOXINE-DEPENDENT EPILEPSY	0.015827734	0.5937956466034171
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015721253999999997	0.5898009269265301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.015717118999999998	0.5896457976453137
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015686154	0.5884841100533266
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230291
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230291
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230291
DESMOSTEROLOSIS	0.015294819999999999	0.5738027649177625
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5693338411019213
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.015175699999999999	0.5693338411019213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.015148273999999998	0.5683049231656112
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
SMITH-MAGENIS SYNDROME; SMS	0.014759403	0.5537159803080729
SMITH-MAGENIS SYNDROME	0.014759403	0.5537159803080729
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014750472999999998	0.5533809610864856
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5343858214162969
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.014244153999999998	0.5343858214162969
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5343858214162969
AYMÃ‰-GRIPP SYNDROME	0.014244153999999998	0.5343858214162969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5343858214162969
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014209053999999999	0.5330690045430931
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014209053999999999	0.5330690045430931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014209053999999999	0.5330690045430931
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014209053999999999	0.5330690045430931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014209053999999999	0.5330690045430931
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014209053999999999	0.5330690045430931
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0140845	0.528396217966882
HYPERPROLINEMIA, TYPE I	0.014058372999999999	0.5274160335097254
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013869853	0.5203434888676638
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5139187355916879
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.5128898176553778
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.013671173999999998	0.5128898176553778
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.013671173999999998	0.5128898176553778
PERLMAN SYNDROME	0.013671173999999998	0.5128898176553778
WRINKLY SKIN SYNDROME	0.013671173999999998	0.5128898176553778
RING CHROMOSOME 14 SYNDROME	0.013671173999999998	0.5128898176553778
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.5126019187184843
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516954	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516954	0.507104076966333
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013516954	0.507104076966333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.507104076966333
KRABBE DISEASE	0.013451114	0.5046340136349446
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.013406842999999998	0.5029731361479474
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.013328434	0.5000315323242713
INFANTILE DYSTONIA-PARKINSONISM	0.013328434	0.5000315323242713
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.013324299	0.499876403043055
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.4866369911417241
LYSOSOMAL ACID LIPASE DEFICIENCY	0.012815754	0.48079775242244593
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.012665073	0.4751447813890782
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012665073	0.4751447813890782
TEMPLE SYNDROME	0.0122702	0.460330666597837
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.012244999999999999	0.45938525961194715
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.012123654000000001	0.45483282484568577
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012119519	0.45467769556446924
MELAS	0.01209078	0.45359951892290234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4516889714560996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4516889714560996
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.4516889714560996
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4516889714560996
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4516889714560996
FUMARASE DEFICIENCY; FMRD	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011974014	0.44921890812471127
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.011929742999999998	0.44755803063771404
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011823333	0.4435659370913436
ALG11-CDG	0.011775523	0.44177228994866924
PROPIONIC ACIDEMIA	0.011700653	0.43896345578067036
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011700653	0.43896345578067036
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.011700653	0.43896345578067036
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.011578100000000001	0.43436573902107684
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4312218856314908
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.011436134	0.42903972123699596
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.01142846	0.42875182230010234
X SMALL RINGS	0.011388324	0.42724607409432164
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.4232539805479511
BIOTINIDASE DEFICIENCY	0.011281914	0.4232539805479511
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4230988512667347
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4230988512667347
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.011229969	0.4213052041240603
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.011187973	0.41972967587884485
XP21 MICRODELETION SYNDROME	0.011187973	0.41972967587884485
GLYCEROL KINASE DEFICIENCY; GKD	0.011187973	0.41972967587884485
ALSTRÃ–M SYNDROME	0.011187973	0.41972967587884485
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011187973	0.41972967587884485
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011155099	0.41849636995606143
XQ12-Q13.3 DUPLICATION SYNDROME	0.01089058	0.40857263541238703
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.40630478413075843
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.4027868947233422
GAUCHER DISEASE TYPE 3	0.01073636	0.4027868947233422
MERRF	0.01073636	0.4027868947233422
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.010696224	0.40128114651756147
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010646554	0.3994177193354524
RECURRENT ACUTE PANCREATITIS	0.010642419	0.3992625900542359
EMANUEL SYNDROME	0.010615482999999998	0.3982520550315403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010298423	0.3863571844384359
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010298423	0.3863571844384359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010298423	0.3863571844384359
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.010298423	0.3863571844384359
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010298423	0.3863571844384359
AICARDI-GOUTIERES SYNDROME 7	0.010298423	0.3863571844384359
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.010298423	0.3863571844384359
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010298423	0.3863571844384359
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.010298423	0.3863571844384359
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.010298423	0.3863571844384359
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010298423	0.3863571844384359
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084346
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.37895063351084346
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.37895063351084346
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084346
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.37895063351084346
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.37895063351084346
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.37895063351084346
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084346
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084346
ALAGILLE SYNDROME 1; ALGS1	0.010101	0.37895063351084346
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.37895063351084346
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.37895063351084346
MANDIBULOACRAL DYSPLASIA	0.010101	0.37895063351084346
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.010101	0.37895063351084346
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.37895063351084346
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.37895063351084346
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.37895063351084346
LCAT DEFICIENCY	0.010101	0.37895063351084346
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.37895063351084346
PROTOPORPHYRIA, ERYTHROPOIETIC	0.010101	0.37895063351084346
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084346
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084346
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.37895063351084346
GLYCOGEN STORAGE DISEASE VI	0.010101	0.37895063351084346
H SYNDROME	0.010101	0.37895063351084346
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010101	0.37895063351084346
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.37895063351084346
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010101	0.37895063351084346
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.010101	0.37895063351084346
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084346
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37895063351084346
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.37895063351084346
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.37895063351084346
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.37895063351084346
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.37895063351084346
GLYCOGEN STORAGE DISEASE IXC	0.010101	0.37895063351084346
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.37895063351084346
ATYPICAL WERNER SYNDROME	0.010101	0.37895063351084346
GLYCOGEN STORAGE DISEASE IXA	0.010101	0.37895063351084346
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.37895063351084346
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.37895063351084346
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.37895063351084346
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.010101	0.37895063351084346
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.37895063351084346
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.37895063351084346
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.37895063351084346
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.37895063351084346
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.37895063351084346
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.37895063351084346
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.37895063351084346
TANGIER DISEASE	0.010101	0.37895063351084346
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.37895063351084346
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.37895063351084346
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.010077603	0.378072868143825
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009936022999999999	0.37276133159373437
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009936022999999999	0.37276133159373437
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3678388750377178
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3678388750377178
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.3678388750377178
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377178
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3678388750377178
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377178
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009760542999999998	0.36617799755072056
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.009760542999999998	0.36617799755072056
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009760542999999998	0.36617799755072056
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.009757004	0.3660452278950434
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.009752868999999999	0.365890098613827
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.009752868999999999	0.365890098613827
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.009752868999999999	0.365890098613827
RETINITIS PIGMENTOSA 59; RP59	0.009752868999999999	0.365890098613827
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.009752868999999999	0.365890098613827
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.009606323	0.36039225686167575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.009606322999999998	0.36039225686167564
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009377828999999999	0.35182004163017117
CARNOSINEMIA	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
GAUCHER DISEASE TYPE 2	0.00925926	0.34737178921310885
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34737178921310885
PAINE SYNDROME	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
1Q44 MICRODELETION SYNDROME	0.009219124	0.34586604100732815
AMISH LETHAL MICROCEPHALY	0.00921145	0.34557814207043447
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00921145	0.34557814207043447
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00921145	0.34557814207043447
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009064904	0.34008030031828324
SARCOSINEMIA	0.009064904	0.34008030031828324
LISSENCEPHALY, X-LINKED, 1; LISX1	0.009060769	0.3399251710370668
CHROMOSOME 13Q14 DELETION SYNDROME	0.00867357	0.3253989551827192
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00851935	0.3196132144936743
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00851935	0.3196132144936743
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00851935	0.3196132144936743
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008458922999999998	0.31734622608350105
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008446282999999999	0.3168720219445468
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008446282999999999	0.3168720219445468
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.008304702999999998	0.31156048539445613
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008129223	0.3049771513514423
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.008129223	0.3049771513514423
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008129223	0.3049771513514423
AICARDI-GOUTIÃˆRES SYNDROME	0.008129223	0.3049771513514423
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008129223	0.3049771513514423
GM2-GANGLIOSIDOSIS, AB VARIANT	0.008129223	0.3049771513514423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.008129223	0.3049771513514423
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.008129223	0.3049771513514423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.008129223	0.3049771513514423
LISSENCEPHALY 8; LIS8	0.008129223	0.3049771513514423
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008129223	0.3049771513514423
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008129223	0.3049771513514423
HEART AND BRAIN MALFORMATION SYNDROME	0.008129223	0.3049771513514423
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.008129223	0.3049771513514423
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.008129223	0.3049771513514423
MEHMO SYNDROME; MEHMO	0.008129223	0.3049771513514423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.008129223	0.3049771513514423
LISSENCEPHALY 1; LIS1	0.008129223	0.3049771513514423
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.008129223	0.3049771513514423
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008129223	0.3049771513514423
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008129223	0.3049771513514423
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.007913369	0.29687914025889217
48,XXYY SYNDROME	0.007766822999999999	0.2913812985067409
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2846651948080499
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2846651948080499
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.007587804	0.2846651948080499
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.007587804	0.2846651948080499
AICARDI-GOUTIERES SYNDROME 5	0.007587804	0.2846651948080499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007587804	0.2846651948080499
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.007587804	0.2846651948080499
W SYNDROME	0.007587804	0.2846651948080499
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2846651948080499
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.007587804	0.2846651948080499
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007587804	0.2846651948080499
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.007587804	0.2846651948080499
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007587804	0.2846651948080499
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007587804	0.2846651948080499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2846651948080499
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2846651948080499
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2846651948080499
TURNPENNY-FRY SYNDROME; TPFS	0.007587804	0.2846651948080499
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007587804	0.2846651948080499
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.007587804	0.2846651948080499
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007587804	0.2846651948080499
PELGER-HUET ANOMALY; PHA	0.007587804	0.2846651948080499
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.007587804	0.2846651948080499
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.007587804	0.2846651948080499
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.007587804	0.2846651948080499
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2846651948080499
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0075836689999999995	0.28451006552683344
DEND SYNDROME	0.0075836689999999995	0.28451006552683344
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.0075836689999999995	0.28451006552683344
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0075836689999999995	0.28451006552683344
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0075836689999999995	0.28451006552683344
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0075836689999999995	0.28451006552683344
WARBURG MICRO SYNDROME 3; WARBM3	0.0075836689999999995	0.28451006552683344
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0075836689999999995	0.28451006552683344
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0075836689999999995	0.28451006552683344
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0075836689999999995	0.28451006552683344
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00735931	0.27609297957654544
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.264198108983441
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
HALLERMANN-STREIFF SYNDROME; HSS	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00704225	0.264198108983441
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.264198108983441
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00704225	0.264198108983441
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00704225	0.264198108983441
WARBURG MICRO SYNDROME 2; WARBM2	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00704225	0.264198108983441
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.264198108983441
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00704225	0.264198108983441
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.264198108983441
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.264198108983441
OLIVER SYNDROME	0.00704225	0.264198108983441
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.264198108983441
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006827603	0.25614537988422287
EMANUEL SYNDROME	0.006827603	0.25614537988422287
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006827603	0.25614537988422287
NEPHROGENIC DIABETES INSIPIDUS	0.006827603	0.25614537988422287
SCHAAF-YANG SYNDROME; SHFYNG	0.006827603	0.25614537988422287
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006827603	0.25614537988422287
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006827603	0.25614537988422287
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006827603	0.25614537988422287
PITT-HOPKINS SYNDROME	0.006827603	0.25614537988422287
DESANTO-SHINAWI SYNDROME	0.006827603	0.25614537988422287
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006827603	0.25614537988422287
PRADER-WILLI-LIKE SYNDROME	0.006827603	0.25614537988422287
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006827603	0.25614537988422287
BARAITSER-WINTER SYNDROME 1; BRWS1	0.006506172999999999	0.244086563714597
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.006506172999999999	0.244086563714597
CHROMOSOME 10Q26 DELETION SYNDROME	0.006506172999999999	0.244086563714597
DISTAL MONOSOMY 10Q	0.006364592999999999	0.2387750271645064
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006364592999999999	0.2387750271645064
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.006351952999999999	0.23830082302555214
SALLA DISEASE	0.006351952999999999	0.23830082302555214
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006351952999999999	0.23830082302555214
HOLOPROSENCEPHALY	0.0062897230000000005	0.23596619299650756
1P36 DELETION SYNDROME	0.0062897230000000005	0.23596619299650756
22Q11.2 DELETION SYNDROME	0.0062897230000000005	0.23596619299650756
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.006289722999999999	0.23596619299650753
49,XXXXY SYNDROME	0.006289722999999999	0.23596619299650753
WIEDEMANN-STEINER SYNDROME; WDSTS	0.006289722999999999	0.23596619299650753
RUBINSTEIN-TAYBI SYNDROME	0.006289722999999999	0.23596619299650753
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.006289722999999999	0.23596619299650753
JACOBSEN SYNDROME	0.006289722999999999	0.23596619299650753
48,XXXY SYNDROME	0.006289722999999999	0.23596619299650753
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.006286184	0.2358334233408304
AU-KLINE SYNDROME; AUKS	0.006286183999999999	0.2358334233408304
PERMANENT CONGENITAL HYPOTHYROIDISM	0.006286183999999999	0.2358334233408304
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006286183999999999	0.2358334233408304
PERIPHERAL HYPOTHYROIDISM	0.006286183999999999	0.2358334233408304
COFFIN-SIRIS SYNDROME 7; CSS7	0.006286183999999999	0.2358334233408304
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006286183999999999	0.2358334233408304
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006286183999999999	0.2358334233408304
ATHYREOSIS	0.006286183999999999	0.2358334233408304
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006286183999999999	0.2358334233408304
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006286183999999999	0.2358334233408304
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.23567829405961396
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.23567829405961396
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.006282049	0.23567829405961396
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.006282049	0.23567829405961396
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.006135502999999999	0.23018045230746265
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.006135502999999999	0.23018045230746265
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.006135502999999999	0.23018045230746265
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.006135502999999999	0.23018045230746265
CUTIS LAXA	0.005964753999999999	0.22377460717120456
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00595708	0.223486708234311
BAKER-GORDON SYNDROME; BAGOS	0.005823173999999999	0.21846307062111395
REVESZ SYNDROME	0.005810533999999999	0.21798886648215968
NEURONAL CEROID LIPOFUSCINOSIS	0.005806399	0.21783373720094326
COFFIN-SIRIS SYNDROME 6; CSS6	0.005748303999999999	0.21565423645311504
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.005748303999999999	0.21565423645311504
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.005744169	0.21549910717189863
MOWAT-WILSON SYNDROME	0.005744169	0.21549910717189863
C SYNDROME	0.005744169	0.21549910717189863
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.005744169	0.21549910717189863
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.005744169	0.21549910717189863
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.005744169	0.21549910717189863
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.005744169	0.21549910717189863
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.005744169	0.21549910717189863
TEMPLE-BARAITSER SYNDROME	0.005744169	0.21549910717189863
SILVER-RUSSELL SYNDROME	0.00574063	0.21536633751622147
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21536633751622147
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00574063	0.21536633751622147
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00574063	0.21536633751622147
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00574063	0.21536633751622147
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21536633751622147
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21536633751622147
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00574063	0.21536633751622147
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005594083999999999	0.20986849576407018
WOLFRAM SYNDROME	0.005589949	0.2097133664828538
ALEXANDER DISEASE	0.005589949	0.2097133664828538
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005589949	0.2097133664828538
2Q23.1 MICRODELETION SYNDROME	0.005589949	0.2097133664828538
GITELMAN SYNDROME	0.005589949	0.2097133664828538
EHLERS-DANLOS SYNDROME, TYPE VI	0.0054192	0.2033075213465957
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.005277619999999999	0.19799598479650504
46,XX GONADAL DYSGENESIS	0.00526498	0.19752178065755077
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19752178065755077
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19752178065755077
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19752178065755077
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19752178065755077
REFSUM DISEASE	0.00526498	0.19752178065755077
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00520275	0.19518715062850617
WILLIAMS-BEUREN SYNDROME; WBS	0.00520275	0.19518715062850617
NEUROFERRITINOPATHY	0.00504853	0.18940140993946128
TYPHOID	0.00504853	0.18940140993946128
TURCOT SYNDROME WITH POLYPOSIS	0.00504853	0.18940140993946128
TETRASOMY 9P	0.004887493	0.18335992165427312
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004887493	0.18335992165427312
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004887493	0.18335992165427312
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.004887493	0.18335992165427312
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004887493	0.18335992165427312
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004887493	0.18335992165427312
8P11.2 DELETION SYNDROME	0.004887493	0.18335992165427312
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.004887493	0.18335992165427312
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004887493	0.18335992165427312
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004887493	0.18335992165427312
11Q22.2Q22.3 MICRODELETION SYNDROME	0.004887493	0.18335992165427312
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004887493	0.18335992165427312
MONOSOMY 9Q22.3	0.004887493	0.18335992165427312
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004887493	0.18335992165427312
PHELAN-MCDERMID SYNDROME	0.004887493	0.18335992165427312
MONOSOMY 22Q13.3	0.004887493	0.18335992165427312
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004887493	0.18335992165427312
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004887493	0.18335992165427312
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.18288571751531887
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004874853	0.18288571751531887
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004874853	0.18288571751531887
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.18288571751531887
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004733273	0.17757418096522826
RFT1-CDG	0.004733273	0.17757418096522826
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.004733273	0.17757418096522826
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004733273	0.17757418096522826
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004733273	0.17757418096522826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004733273	0.17757418096522826
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004733273	0.17757418096522826
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004733273	0.17757418096522826
JOUBERT SYNDROME WITH OCULAR DEFECT	0.004733273	0.17757418096522826
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004733273	0.17757418096522826
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004733273	0.17757418096522826
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004733273	0.17757418096522826
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004733273	0.17757418096522826
JOUBERT SYNDROME WITH RENAL DEFECT	0.004733273	0.17757418096522826
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004733273	0.17757418096522826
XQ28 (MECP2) DUPLICATION	0.004658403	0.17476534679722935
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.17476534679722935
FG SYNDROME TYPE 1	0.004658403	0.17476534679722935
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.17476534679722935
611961 STEVENSON-CAREY SYNDROME	0.004658403	0.17476534679722935
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004658403	0.17476534679722935
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004658403	0.17476534679722935
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.17476534679722935
HOLOPROSENCEPHALY 2; HPE2	0.004658403	0.17476534679722935
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004658403	0.17476534679722935
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.17476534679722935
KLEEFSTRA SYNDROME	0.004658403	0.17476534679722935
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004658403	0.17476534679722935
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004658403	0.17476534679722935
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.17476534679722935
KAGAMI-OGATA SYNDROME	0.004658403	0.17476534679722935
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004346073999999999	0.16304796511088063
16P11.2P12.2 MICRODELETION SYNDROME	0.004346073999999999	0.16304796511088063
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004346073999999999	0.16304796511088063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004346073999999999	0.16304796511088063
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004346073999999999	0.16304796511088063
48,XYYY SYNDROME	0.004346073999999999	0.16304796511088063
HOLMES-GANG SYNDROME	0.004346073999999999	0.16304796511088063
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.004346073999999999	0.16304796511088063
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004346073999999999	0.16304796511088063
2P15P16.1 MICRODELETION SYNDROME	0.004346073999999999	0.16304796511088063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.004346073999999999	0.16304796511088063
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004346073999999999	0.16304796511088063
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004346073999999999	0.16304796511088063
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004346073999999999	0.16304796511088063
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004346073999999999	0.16304796511088063
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004346073999999999	0.16304796511088063
PALLISTER-KILLIAN SYNDROME	0.0043419389999999995	0.16289283582966418
WIEDEMANN-STEINER SYNDROME	0.0043419389999999995	0.16289283582966418
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0043419389999999995	0.16289283582966418
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0043419389999999995	0.16289283582966418
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0043419389999999995	0.16289283582966418
DUPLICATION/INVERSION 15Q11	0.0043419389999999995	0.16289283582966418
14Q12 MICRODELETION SYNDROME	0.0043419389999999995	0.16289283582966418
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.16257376097192638
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.16257376097192638
LARSEN-LIKE SYNDROME	0.004333434	0.16257376097192638
NEONATAL ADRENOLEUKODYSTROPHY	0.004329299	0.16241863169070994
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.16241863169070994
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.16241863169070994
XYLOSIDASE DEFICIENCY	0.004329299	0.16241863169070994
ASPARTYLGLUCOSAMINURIA; AGU	0.004329299	0.16241863169070994
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.16241863169070994
EPILEPSY-TELANGIECTASIA	0.004329299	0.16241863169070994
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.004329299	0.16241863169070994
GAPO SYNDROME; GAPOS	0.004329299	0.16241863169070994
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004329299	0.16241863169070994
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.16241863169070994
OROFACIODIGITAL SYNDROME TYPE 6	0.0041953929999999995	0.1573949940775129
15Q11Q13 MICRODUPLICATION SYNDROME	0.0041953929999999995	0.1573949940775129
PYRUVATE DEHYDROGENASE DEFICIENCY	0.0041953929999999995	0.1573949940775129
WOLF-HIRSCHHORN SYNDROME	0.0041953929999999995	0.1573949940775129
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0041953929999999995	0.1573949940775129
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0041953929999999995	0.1573949940775129
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0041953929999999995	0.1573949940775129
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0041953929999999995	0.1573949940775129
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0041953929999999995	0.1573949940775129
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004191853999999999	0.15726222442183574
ISOLATED COMPLEX I DEFICIENCY	0.004191853999999999	0.15726222442183574
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004191853999999999	0.15726222442183574
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004191853999999999	0.15726222442183574
CITRULLINEMIA TYPE I	0.0041877189999999995	0.15710709514061932
CHOREOACANTHOCYTOSIS	0.0041877189999999995	0.15710709514061932
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0041877189999999995	0.15710709514061932
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0041877189999999995	0.15710709514061932
COCKAYNE SYNDROME	0.0041877189999999995	0.15710709514061932
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.0041877189999999995	0.15710709514061932
PROPIONIC ACIDEMIA	0.004116984	0.15445339025383686
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.004116984	0.15445339025383686
NIEMANN-PICK DISEASE, TYPE A	0.004116984	0.15445339025383686
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.004116984	0.15445339025383686
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.004116984	0.15445339025383686
300270 ADRENOMYODYSTROPHY	0.004116984	0.15445339025383686
FLOATING-HARBOR SYNDROME	0.004116984	0.15445339025383686
CONGENITAL HYPOTHYROIDISM	0.004116984	0.15445339025383686
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004116984	0.15445339025383686
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.004116984	0.15445339025383686
THYROID HYPOPLASIA	0.004116984	0.15445339025383686
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.004116984	0.15445339025383686
THYROID HEMIAGENESIS	0.004116984	0.15445339025383686
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.15445339025383686
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.15445339025383686
THYROID ECTOPIA	0.004116984	0.15445339025383686
FAMILIAL THYROID DYSHORMONOGENESIS	0.004116984	0.15445339025383686
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004116984	0.15445339025383686
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004116984	0.15445339025383686
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262045
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.004112849	0.15429826097262045
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262045
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15429826097262045
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262045
FAMILIAL COLORECTAL CANCER TYPE X	0.004112849	0.15429826097262045
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262045
PORPHYRIA	0.004112849	0.15429826097262045
RETT SYNDROME; RTT	0.004112849	0.15429826097262045
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262045
DDOST-CDG	0.004112849	0.15429826097262045
PITT-HOPKINS SYNDROME	0.004112849	0.15429826097262045
LYNCH SYNDROME	0.004112849	0.15429826097262045
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.15429826097262045
ADDISON DISEASE	0.004112849	0.15429826097262045
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262045
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.004112849	0.15429826097262045
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262045
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262045
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262045
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262045
OCULOCEREBRORENAL SYNDROME OF LOWE	0.004112849	0.15429826097262045
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262045
KAPUR-TORIELLO SYNDROME	0.004112849	0.15429826097262045
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262045
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15429826097262045
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262045
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262045
TRISOMY 8P	0.004112849	0.15429826097262045
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262045
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262045
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262045
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0038005199999999995	0.14258087928627172
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0038005199999999995	0.14258087928627172
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0038005199999999995	0.14258087928627172
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0038005199999999995	0.14258087928627172
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0038005199999999995	0.14258087928627172
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0038005199999999995	0.14258087928627172
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0038005199999999995	0.14258087928627172
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.14210667514731745
ACETYLATION, SLOW	0.00378788	0.14210667514731745
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.14210667514731745
HYPOASCORBEMIA	0.00378788	0.14210667514731745
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.14210667514731745
HOOFT DISEASE	0.00378788	0.14210667514731745
GLUTATHIONURIA	0.00378788	0.14210667514731745
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.14210667514731745
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.14210667514731745
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.14210667514731745
ETHANOLAMINOSIS	0.00378788	0.14210667514731745
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.14210667514731745
LIPASE DEFICIENCY, COMBINED	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.14210667514731745
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.14210667514731745
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.14210667514731745
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.14210667514731745
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.14210667514731745
DERMATOLEUKODYSTROPHY	0.00378788	0.14210667514731745
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.14210667514731745
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.14210667514731745
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.14210667514731745
CITRULLINE TRANSPORT DEFECT	0.00378788	0.14210667514731745
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.14210667514731745
CEPHALIN LIPIDOSIS	0.00378788	0.14210667514731745
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.14210667514731745
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.14210667514731745
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.14210667514731745
OSTEOGENIC SARCOMA	0.00378788	0.14210667514731745
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.14210667514731745
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.14210667514731745
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.14210667514731745
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.14210667514731745
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.14210667514731745
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.14210667514731745
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.14210667514731745
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.14210667514731745
NEPHROSIALIDOSIS	0.00378788	0.14210667514731745
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.14210667514731745
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.14210667514731745
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.14210667514731745
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.14210667514731745
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.14210667514731745
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.14210667514731745
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.14210667514731745
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.14210667514731745
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.14210667514731745
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.14210667514731745
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.14210667514731745
LYMPHOKINE DEFICIENCY	0.00378788	0.14210667514731745
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.14210667514731745
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.14210667514731745
AREDYLD	0.00378788	0.14210667514731745
PARAOXONASE 1	0.00378788	0.14210667514731745
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.14210667514731745
PACMAN DYSPLASIA	0.00378788	0.14210667514731745
OVARIAN CANCER	0.00378788	0.14210667514731745
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.14210667514731745
APOLIPOPROTEIN(A)	0.00378788	0.14210667514731745
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.14210667514731745
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.14210667514731745
HYPERPROGLUCAGONEMIA	0.00378788	0.14210667514731745
HEINZ BODY ANEMIAS	0.00378788	0.14210667514731745
GLUTATHIONE REDUCTASE	0.00378788	0.14210667514731745
GLOMUVENOUS MALFORMATIONS	0.00378788	0.14210667514731745
FLOOD FACTOR DEFICIENCY	0.00378788	0.14210667514731745
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.14210667514731745
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.14210667514731745
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.14210667514731745
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.14210667514731745
COUMARIN RESISTANCE	0.00378788	0.14210667514731745
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.14210667514731745
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.14210667514731745
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.14210667514731745
CARBOXYLESTERASE 1	0.00378788	0.14210667514731745
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.14210667514731745
BEETURIA	0.00378788	0.14210667514731745
MACULAR CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.14210667514731745
PERRY SYNDROME	0.00378788	0.14210667514731745
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.14210667514731745
PITUITARY DWARFISM IV	0.00378788	0.14210667514731745
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.14210667514731745
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.14210667514731745
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.14210667514731745
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.14210667514731745
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.14210667514731745
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.14210667514731745
ALKAPTONURIA	0.00378788	0.14210667514731745
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.14210667514731745
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00378788	0.14210667514731745
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.14210667514731745
ZINC, ELEVATED PLASMA	0.00378788	0.14210667514731745
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.14210667514731745
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.14210667514731745
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.14210667514731745
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.14210667514731745
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.14210667514731745
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.14210667514731745
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.14210667514731745
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.14210667514731745
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.14210667514731745
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.14210667514731745
SPINAL ARACHNOIDITIS	0.00378788	0.14210667514731745
MYOPATHY, SPHEROID BODY	0.00378788	0.14210667514731745
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.14210667514731745
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.14210667514731745
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.14210667514731745
LARON SYNDROME	0.00378788	0.14210667514731745
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.14210667514731745
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.14210667514731745
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.14210667514731745
DELETED IN AZOOSPERMIA	0.00378788	0.14210667514731745
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.14210667514731745
XM SYSTEM	0.00378788	0.14210667514731745
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.14210667514731745
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.14210667514731745
PENDRED SYNDROME	0.00378788	0.14210667514731745
BARTTER SYNDROME	0.00378788	0.14210667514731745
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.14210667514731745
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.14210667514731745
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.14210667514731745
OSTEOMESOPYKNOSIS	0.00378788	0.14210667514731745
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.14210667514731745
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.14210667514731745
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.14210667514731745
GONADOBLASTOMA	0.00378788	0.14210667514731745
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.14210667514731745
ONCOCYTOMA	0.00378788	0.14210667514731745
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.14210667514731745
MACROCYTOSIS, FAMILIAL	0.00378788	0.14210667514731745
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.14210667514731745
CALVARIAL HYPEROSTOSIS	0.00378788	0.14210667514731745
SCHIZOPHRENIA 4	0.00378788	0.14210667514731745
XANTHINURIA, TYPE I	0.00378788	0.14210667514731745
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.14210667514731745
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.14210667514731745
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.14210667514731745
TRISOMY 18-LIKE SYNDROME	0.00378788	0.14210667514731745
T-SUBSTANCE ANOMALY	0.00378788	0.14210667514731745
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.14210667514731745
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.14210667514731745
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.14210667514731745
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.14210667514731745
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.14210667514731745
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.14210667514731745
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.14210667514731745
PYGMY	0.00378788	0.14210667514731745
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.14210667514731745
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.14210667514731745
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.14210667514731745
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00378788	0.14210667514731745
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.14210667514731745
ICHTHYOSIS, X-LINKED	0.00378788	0.14210667514731745
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.14210667514731745
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.14210667514731745
PROGESTERONE RESISTANCE	0.00378788	0.14210667514731745
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.14210667514731745
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.14210667514731745
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.14210667514731745
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.14210667514731745
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.14210667514731745
PREMATURE OVARIAN FAILURE 1	0.00378788	0.14210667514731745
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.14210667514731745
FINGERPRINT BODY MYOPATHY	0.00378788	0.14210667514731745
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.14210667514731745
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.14210667514731745
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00378788	0.14210667514731745
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.14210667514731745
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.14210667514731745
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.14210667514731745
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.14210667514731745
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.14210667514731745
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.14210667514731745
ALAND ISLAND EYE DISEASE	0.00378788	0.14210667514731745
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00378788	0.14210667514731745
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.14210667514731745
DERMATITIS, ATOPIC	0.00378788	0.14210667514731745
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0036539739999999995	0.13708303753412046
JOUBERT SYNDROME 14	0.0036539739999999995	0.13708303753412046
JOUBERT SYNDROME 1	0.0036539739999999995	0.13708303753412046
CEREBROFACIOARTICULAR SYNDROME	0.0036539739999999995	0.13708303753412046
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.0036539739999999995	0.13708303753412046
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0036498389999999998	0.136927908252904
OROFACIODIGITAL SYNDROME TYPE 1	0.0036498389999999998	0.136927908252904
MILLER-DIEKER SYNDROME	0.0036498389999999998	0.136927908252904
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0036498389999999998	0.136927908252904
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.0036498389999999998	0.136927908252904
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0036498389999999998	0.136927908252904
OCULODENTODIGITAL DYSPLASIA	0.0036498389999999998	0.136927908252904
CHIARI MALFORMATION TYPE II	0.0036462999999999995	0.13679513859722683
CLASSIC GALACTOSEMIA	0.0036462999999999995	0.13679513859722683
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0036462999999999995	0.13679513859722683
WAARDENBURG-SHAH SYNDROME	0.00357143	0.13398630442922796
TOWNES-BROCKS SYNDROME	0.00357143	0.13398630442922796
ATTRV30M AMYLOIDOSIS	0.00357143	0.13398630442922796
PANHYPOPITUITARISM	0.00357143	0.13398630442922796
PORPHYRIA VARIEGATA	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.13398630442922796
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13398630442922796
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13398630442922796
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13398630442922796
SOMATOSTATINOMA	0.00357143	0.13398630442922796
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13398630442922796
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13398630442922796
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13398630442922796
ADIPOSIS DOLOROSA	0.00357143	0.13398630442922796
RHEUMATIC FEVER	0.00357143	0.13398630442922796
INFANT BOTULISM	0.00357143	0.13398630442922796
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.13398630442922796
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.13398630442922796
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00357143	0.13398630442922796
KAPUR-TORIELLO SYNDROME	0.00357143	0.13398630442922796
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.13398630442922796
WOUND BOTULISM	0.00357143	0.13398630442922796
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.13398630442922796
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13398630442922796
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.13398630442922796
GLUCAGONOMA	0.00357143	0.13398630442922796
PPOMA	0.00357143	0.13398630442922796
GRFOMA	0.00357143	0.13398630442922796
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13398630442922796
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13398630442922796
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13398630442922796
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13398630442922796
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13398630442922796
VISCERAL MYOPATHY; VSCM	0.00357143	0.13398630442922796
FOODBORNE BOTULISM	0.00357143	0.13398630442922796
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13398630442922796
JUVENILE DERMATOMYOSITIS	0.00357143	0.13398630442922796
SHEEHAN SYNDROME	0.00357143	0.13398630442922796
CAP POLYPOSIS	0.00357143	0.13398630442922796
PARATHYROID CARCINOMA	0.00357143	0.13398630442922796
IATROGENIC BOTULISM	0.00357143	0.13398630442922796
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00357143	0.13398630442922796
HIRSCHSPRUNG DISEASE	0.00357143	0.13398630442922796
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.13398630442922796
LIDDLE SYNDROME	0.00357143	0.13398630442922796
BOTULISM	0.00357143	0.13398630442922796
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.13398630442922796
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13398630442922796
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13398630442922796
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00357143	0.13398630442922796
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.13398630442922796
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13398630442922796
UROFACIAL SYNDROME 2	0.00357143	0.13398630442922796
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13398630442922796
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.13398630442922796
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13398630442922796
PRUNE BELLY SYNDROME	0.00357143	0.13398630442922796
FG SYNDROME 2; FGS2	0.00357143	0.13398630442922796
PURE AUTONOMIC FAILURE	0.00357143	0.13398630442922796
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.13398630442922796
MULTIPLE SYSTEM ATROPHY	0.00357143	0.13398630442922796
POLYMYOSITIS	0.00357143	0.13398630442922796
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13398630442922796
PUDENDAL NEURALGIA	0.00357143	0.13398630442922796
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13398630442922796
UROFACIAL SYNDROME	0.00357143	0.13398630442922796
MALT LYMPHOMA	0.00357143	0.13398630442922796
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13398630442922796
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.13398630442922796
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.13398630442922796
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13398630442922796
HINMAN SYNDROME	0.00357143	0.13398630442922796
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.13398630442922796
INHALATIONAL BOTULISM	0.00357143	0.13398630442922796
OCHOA SYNDROME	0.00357143	0.13398630442922796
NK-CELL ENTEROPATHY	0.00357143	0.13398630442922796
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13398630442922796
MYXEDEMA	0.00357143	0.13398630442922796
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.13398630442922796
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13398630442922796
PSEUDOMYXOMA PERITONEI	0.00357143	0.13398630442922796
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13398630442922796
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.003256173	0.12215907545499491
WIEACKER-WOLFF SYNDROME	0.003256173	0.12215907545499491
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003256173	0.12215907545499491
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.003256173	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.003256173	0.12215907545499491
HELSMOORTEL-VAN DER AA SYNDROME	0.0032561729999999994	0.12215907545499491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0032561729999999994	0.12215907545499491
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0032561729999999994	0.12215907545499491
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0032561729999999994	0.12215907545499491
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.0032561729999999994	0.12215907545499491
ZTTK SYNDROME; ZTTKS	0.0032561729999999994	0.12215907545499491
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0032561729999999994	0.12215907545499491
COFFIN-SIRIS SYNDROME 5	0.0032561729999999994	0.12215907545499491
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0032561729999999994	0.12215907545499491
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0032561729999999994	0.12215907545499491
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0032561729999999994	0.12215907545499491
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.0032561729999999994	0.12215907545499491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0032561729999999994	0.12215907545499491
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0032561729999999994	0.12215907545499491
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0032561729999999994	0.12215907545499491
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0032561729999999994	0.12215907545499491
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0032561729999999994	0.12215907545499491
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0032561729999999994	0.12215907545499491
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0032561729999999994	0.12215907545499491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0032561729999999994	0.12215907545499491
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0032561729999999994	0.12215907545499491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0032561729999999994	0.12215907545499491
COFFIN-SIRIS SYNDROME 4; CSS4	0.0032561729999999994	0.12215907545499491
COFFIN-SIRIS SYNDROME 3; CSS3	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0032561729999999994	0.12215907545499491
COFFIN-SIRIS SYNDROME 2; CSS2	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0032561729999999994	0.12215907545499491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0032561729999999994	0.12215907545499491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0032561729999999994	0.12215907545499491
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0032561729999999994	0.12215907545499491
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0032561729999999994	0.12215907545499491
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0032561729999999994	0.12215907545499491
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0032561729999999994	0.12215907545499491
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0032561729999999994	0.12215907545499491
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0032561729999999994	0.12215907545499491
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0032561729999999994	0.12215907545499491
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0032561729999999994	0.12215907545499491
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0032561729999999994	0.12215907545499491
PIERPONT SYNDROME	0.0032561729999999994	0.12215907545499491
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0032561729999999994	0.12215907545499491
STT3A-CDG	0.0032561729999999994	0.12215907545499491
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.0032561729999999994	0.12215907545499491
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.0032561729999999994	0.12215907545499491
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0032561729999999994	0.12215907545499491
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.12215907545499491
SSR4-CDG	0.0032561729999999994	0.12215907545499491
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0032561729999999994	0.12215907545499491
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0032561729999999994	0.12215907545499491
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0032561729999999994	0.12215907545499491
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0032561729999999994	0.12215907545499491
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0032561729999999994	0.12215907545499491
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0032561729999999994	0.12215907545499491
STT3B-CDG	0.0032561729999999994	0.12215907545499491
GAUCHER DISEASE, TYPE II	0.0032561729999999994	0.12215907545499491
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.0032561729999999994	0.12215907545499491
17Q12 MICRODELETION SYNDROME	0.0032561729999999994	0.12215907545499491
BOHRING-OPITZ SYNDROME	0.0032561729999999994	0.12215907545499491
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0032561729999999994	0.12215907545499491
GENITOPATELLAR SYNDROME	0.0032561729999999994	0.12215907545499491
KBG SYNDROME	0.0032561729999999994	0.12215907545499491
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0032561729999999994	0.12215907545499491
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0032561729999999994	0.12215907545499491
JOUBERT SYNDROME 3; JBTS3	0.0031084199999999998	0.11661595170951154
NON-DISTAL MONOSOMY 10Q	0.0031084199999999998	0.11661595170951154
LAURENCE-MOON SYNDROME	0.0031084199999999998	0.11661595170951154
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0027182929999999997	0.10197988856727959
LATHOSTEROLOSIS	0.0027182929999999997	0.10197988856727959
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
WEAVER SYNDROME	0.0027182929999999997	0.10197988856727959
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0027182929999999997	0.10197988856727959
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0027182929999999997	0.10197988856727959
KOOLEN-DE VRIES SYNDROME	0.0027182929999999997	0.10197988856727959
INFANTILE SIALIC ACID STORAGE DISEASE	0.0027182929999999997	0.10197988856727959
KOOLEN-DE VRIES SYNDROME; KDVS	0.0027182929999999997	0.10197988856727959
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0027182929999999997	0.10197988856727959
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0027182929999999997	0.10197988856727959
SMITH-LEMLI-OPITZ SYNDROME	0.0027182929999999997	0.10197988856727959
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0027182929999999997	0.10197988856727959
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0027182929999999997	0.10197988856727959
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0027182929999999997	0.10197988856727959
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0027182929999999997	0.10197988856727959
PEHO SYNDROME; PEHO	0.0027182929999999997	0.10197988856727959
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0027182929999999997	0.10197988856727959
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10197988856727959
20P12.3 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0027182929999999997	0.10197988856727959
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0027182929999999997	0.10197988856727959
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0027182929999999997	0.10197988856727959
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0027182929999999997	0.10197988856727959
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0027182929999999997	0.10197988856727959
MONOSOMY 18Q	0.0027182929999999997	0.10197988856727959
OCULOECTODERMAL SYNDROME; OES	0.0027182929999999997	0.10197988856727959
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.0027182929999999997	0.10197988856727959
TRISOMY X	0.0027182929999999997	0.10197988856727959
DISTAL TRISOMY 17Q	0.0027182929999999997	0.10197988856727959
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0027182929999999997	0.10197988856727959
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0027182929999999997	0.10197988856727959
COFFIN-SIRIS SYNDROME	0.0027182929999999997	0.10197988856727959
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0027182929999999997	0.10197988856727959
RING CHROMOSOME 22 SYNDROME	0.0027182929999999997	0.10197988856727959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0027182929999999997	0.10197988856727959
SIALURIA	0.0027182929999999997	0.10197988856727959
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0027182929999999997	0.10197988856727959
22Q11.2 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10197988856727959
20Q11.2 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10197988856727959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0027182929999999997	0.10197988856727959
15Q24 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
DISTAL MONOSOMY 1Q	0.0027182929999999997	0.10197988856727959
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0027182929999999997	0.10197988856727959
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.10197988856727959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0027182929999999997	0.10197988856727959
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0027182929999999997	0.10197988856727959
AL KAISSI SYNDROME; ALKAS	0.0027182929999999997	0.10197988856727959
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0027182929999999997	0.10197988856727959
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.10197988856727959
MAN1B1-CDG	0.0027182929999999997	0.10197988856727959
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0027182929999999997	0.10197988856727959
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0027182929999999997	0.10197988856727959
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0027182929999999997	0.10197988856727959
WITTEVEEN-KOLK SYNDROME	0.0027182929999999997	0.10197988856727959
2Q31.1 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0027182929999999997	0.10197988856727959
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0027182929999999997	0.10197988856727959
XQ25 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10197988856727959
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0027182929999999997	0.10197988856727959
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0027182929999999997	0.10197988856727959
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0027182929999999997	0.10197988856727959
19P13.12 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0027182929999999997	0.10197988856727959
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0027182929999999997	0.10197988856727959
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0027182929999999997	0.10197988856727959
1Q21.1 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
MATERNAL PHENYLKETONURIA	0.0027182929999999997	0.10197988856727959
POTOCKI-SHAFFER SYNDROME	0.0027182929999999997	0.10197988856727959
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0027182929999999997	0.10197988856727959
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0027182929999999997	0.10197988856727959
C SYNDROME	0.0027182929999999997	0.10197988856727959
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.10197988856727959
MONOSOMY 9P	0.0027182929999999997	0.10197988856727959
6Q25 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
8P23.1 MICRODELETION SYNDROME	0.0027182929999999997	0.10197988856727959
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.0027147539999999998	0.10184711891160245
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0027147539999999998	0.10184711891160245
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.10184711891160245
SPINOCEREBELLAR ATAXIA TYPE 7	0.0027147539999999998	0.10184711891160245
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027147539999999998	0.10184711891160245
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.10184711891160245
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.10184711891160245
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0027147539999999998	0.10184711891160245
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.10184711891160245
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.10184711891160245
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.10184711891160245
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.10184711891160245
PRIMARY CONGENITAL HYPOTHYROIDISM	0.0027147539999999998	0.10184711891160245
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.10184711891160245
MARDEN-WALKER SYNDROME	0.0027147539999999998	0.10184711891160245
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.10184711891160245
EAR-PATELLA-SHORT STATURE SYNDROME	0.0027147539999999998	0.10184711891160245
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.10184711891160245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0027147539999999998	0.10184711891160245
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.10184711891160245
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.10184711891160245
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.10184711891160245
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.10184711891160245
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.10184711891160245
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0027147539999999998	0.10184711891160245
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.10184711891160245
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.10184711891160245
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.10184711891160245
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.10184711891160245
TYSHCHENKO SYNDROME	0.0027147539999999998	0.10184711891160245
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0027147539999999998	0.10184711891160245
2Q32Q33 MICRODELETION SYNDROME	0.0027147539999999998	0.10184711891160245
HURLER SYNDROME	0.0027147539999999998	0.10184711891160245
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.10184711891160245
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.10184711891160245
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.10184711891160245
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0027147539999999998	0.10184711891160245
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.10184711891160245
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0027106189999999996	0.10169198963038599
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0027106189999999996	0.10169198963038599
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0027106189999999996	0.10169198963038599
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0027106189999999996	0.10169198963038599
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0027106189999999996	0.10169198963038599
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0027106189999999996	0.10169198963038599
5Q14.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
KABUKI SYNDROME	0.0027106189999999996	0.10169198963038599
CRISPONI SYNDROME	0.0027106189999999996	0.10169198963038599
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.0027106189999999996	0.10169198963038599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0027106189999999996	0.10169198963038599
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.0027106189999999996	0.10169198963038599
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.10169198963038599
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0027106189999999996	0.10169198963038599
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.10169198963038599
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.10169198963038599
16Q24.3 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0027106189999999996	0.10169198963038599
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.10169198963038599
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0027106189999999996	0.10169198963038599
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.10169198963038599
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.10169198963038599
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0027106189999999996	0.10169198963038599
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.10169198963038599
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.0027106189999999996	0.10169198963038599
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0027106189999999996	0.10169198963038599
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0027106189999999996	0.10169198963038599
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0027106189999999996	0.10169198963038599
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0027106189999999996	0.10169198963038599
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0027106189999999996	0.10169198963038599
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.10169198963038599
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.10169198963038599
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.10169198963038599
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0025640729999999996	0.09619414787823471
PELIZAEUS-MERZBACHER DISEASE	0.0025640729999999996	0.09619414787823471
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0025640729999999996	0.09619414787823471
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0025640729999999996	0.09619414787823471
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0025640729999999996	0.09619414787823471
ELEJALDE DISEASE	0.0025640729999999996	0.09619414787823471
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0025640729999999996	0.09619414787823471
GALACTOSEMIA	0.0025640729999999996	0.09619414787823471
COACH SYNDROME	0.0025640729999999996	0.09619414787823471
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0025640729999999996	0.09619414787823471
FOLATE MALABSORPTION, HEREDITARY	0.0025640729999999996	0.09619414787823471
INFANTILE REFSUM DISEASE	0.0025640729999999996	0.09619414787823471
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.0025640729999999996	0.09619414787823471
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0025640729999999996	0.09619414787823471
CITRULLINEMIA, CLASSIC	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0025640729999999996	0.09619414787823471
LEIGH SYNDROME; LS	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0025640729999999996	0.09619414787823471
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0025640729999999996	0.09619414787823471
MAPLE SYRUP URINE DISEASE	0.0025640729999999996	0.09619414787823471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0025640729999999996	0.09619414787823471
HSD10 DISEASE	0.0025640729999999996	0.09619414787823471
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.0025640729999999996	0.09619414787823471
TAY-SACHS DISEASE	0.0025640729999999996	0.09619414787823471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0025640729999999996	0.09619414787823471
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0025640729999999996	0.09619414787823471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0025640729999999996	0.09619414787823471
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0025640729999999996	0.09619414787823471
SULFOCYSTEINURIA	0.0025640729999999996	0.09619414787823471
GRISCELLI SYNDROME TYPE 1	0.0025640729999999996	0.09619414787823471
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0025640729999999996	0.09619414787823471
JOUBERT SYNDROME	0.0025640729999999996	0.09619414787823471
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0025640729999999996	0.09619414787823471
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0025640729999999996	0.09619414787823471
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0025640729999999996	0.09619414787823471
NIEMANN-PICK DISEASE TYPE C	0.0025640729999999996	0.09619414787823471
ARGININOSUCCINIC ACIDURIA	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0025640729999999996	0.09619414787823471
FREE SIALIC ACID STORAGE DISEASE	0.0025640729999999996	0.09619414787823471
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0025640729999999996	0.09619414787823471
CEDNIK SYNDROME	0.0025640729999999996	0.09619414787823471
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0025640729999999996	0.09619414787823471
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0025640729999999996	0.09619414787823471
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025640729999999996	0.09619414787823471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0025640729999999996	0.09619414787823471
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0025640729999999996	0.09619414787823471
SIALIDOSIS TYPE 2	0.0025640729999999996	0.09619414787823471
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0025640729999999996	0.09619414787823471
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0025640729999999996	0.09619414787823471
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0025640729999999996	0.09619414787823471
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0025640729999999996	0.09619414787823471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0025640729999999996	0.09619414787823471
SRD5A3-CDG	0.0025640729999999996	0.09619414787823471
EAST SYNDROME	0.0025640729999999996	0.09619414787823471
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.0025640729999999996	0.09619414787823471
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0025640729999999996	0.09619414787823471
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0025640729999999996	0.09619414787823471
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0025640729999999996	0.09619414787823471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0025640729999999996	0.09619414787823471
CHROMOSOME 1P35 DELETION SYNDROME	0.0025640729999999996	0.09619414787823471
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0025640729999999996	0.09619414787823471
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025640729999999996	0.09619414787823471
COWDEN SYNDROME	0.0025640729999999996	0.09619414787823471
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.0025640729999999996	0.09619414787823471
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0025640729999999996	0.09619414787823471
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0025640729999999996	0.09619414787823471
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0025640729999999996	0.09619414787823471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0025640729999999996	0.09619414787823471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0025640729999999996	0.09619414787823471
MEVALONIC ACIDURIA	0.0025640729999999996	0.09619414787823471
HARTNUP DISEASE	0.0025640729999999996	0.09619414787823471
CENTRAL BILATERAL MACROGYRIA	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.0025640729999999996	0.09619414787823471
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0025640729999999996	0.09619414787823471
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0025640729999999996	0.09619414787823471
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0025640729999999996	0.09619414787823471
MYHRE SYNDROME	0.0025640729999999996	0.09619414787823471
CHÃ‰DIAK-HIGASHI SYNDROME	0.0025640729999999996	0.09619414787823471
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0025640729999999996	0.09619414787823471
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0025640729999999996	0.09619414787823471
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.0025640729999999996	0.09619414787823471
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0025640729999999996	0.09619414787823471
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0025640729999999996	0.09619414787823471
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0025640729999999996	0.09619414787823471
JOUBERT SYNDROME 10	0.0021768739999999996	0.08166793202388711
MONOSOMY 13Q34	0.0021768739999999996	0.08166793202388711
OGDEN SYNDROME; OGDNS	0.0021768739999999996	0.08166793202388711
DISTAL MONOSOMY 6P	0.0021768739999999996	0.08166793202388711
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.08166793202388711
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.08166793202388711
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.08166793202388711
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.08166793202388711
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.08166793202388711
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021768739999999996	0.08166793202388711
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0021768739999999996	0.08166793202388711
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.08166793202388711
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.08166793202388711
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.08166793202388711
FANCONI ANEMIA	0.0021768739999999996	0.08166793202388711
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.08166793202388711
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.08166793202388711
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.08166793202388711
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.08166793202388711
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.08166793202388711
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.08166793202388711
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0021768739999999996	0.08166793202388711
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.08166793202388711
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021768739999999996	0.08166793202388711
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0021768739999999996	0.08166793202388711
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.08166793202388711
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0021768739999999996	0.08166793202388711
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0021768739999999996	0.08166793202388711
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.08166793202388711
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021768739999999996	0.08166793202388711
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.08166793202388711
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.08166793202388711
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.08166793202388711
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.08166793202388711
LIG4 SYNDROME	0.0021768739999999996	0.08166793202388711
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08166793202388711
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388711
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.08166793202388711
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0021768739999999996	0.08166793202388711
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0021768739999999996	0.08166793202388711
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.08166793202388711
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.08166793202388711
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.08166793202388711
ICF SYNDROME	0.0021768739999999996	0.08166793202388711
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.08166793202388711
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.08166793202388711
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.08166793202388711
17Q21.31 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388711
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.08166793202388711
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.08166793202388711
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0021768739999999996	0.08166793202388711
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.08166793202388711
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.08166793202388711
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.08166793202388711
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0021768739999999996	0.08166793202388711
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.08166793202388711
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.08166793202388711
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.08166793202388711
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.08166793202388711
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.08166793202388711
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.08166793202388711
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0021768739999999996	0.08166793202388711
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.08166793202388711
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.08166793202388711
FETAL TRIMETHADIONE SYNDROME	0.0021768739999999996	0.08166793202388711
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.08166793202388711
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.08166793202388711
DE BARSY SYNDROME	0.0021768739999999996	0.08166793202388711
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.08166793202388711
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.08166793202388711
CHARGE SYNDROME	0.0021768739999999996	0.08166793202388711
CHROMOSOME 9P DELETION SYNDROME	0.0021768739999999996	0.08166793202388711
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.08166793202388711
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.08166793202388711
PHENOBARBITAL EMBRYOPATHY	0.0021768739999999996	0.08166793202388711
6Q16 MICRODELETION SYNDROME	0.0021768739999999996	0.08166793202388711
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.08166793202388711
CODAS SYNDROME	0.0021768739999999996	0.08166793202388711
TRISOMY 12P	0.0021768739999999996	0.08166793202388711
TRISOMY 18	0.0021768739999999996	0.08166793202388711
DISTAL MONOSOMY 9P	0.0021768739999999996	0.08166793202388711
MONOSOMY 18P	0.0021768739999999996	0.08166793202388711
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.08166793202388711
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.08166793202388711
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.08166793202388711
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.08166793202388711
TETRASOMY X	0.0021768739999999996	0.08166793202388711
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.08166793202388711
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.08166793202388711
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.08166793202388711
BARATELA-SCOTT SYNDROME	0.0021768739999999996	0.08166793202388711
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.08166793202388711
VASCULAR EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.08166793202388711
MOMO SYNDROME	0.002172739	0.08151280274267067
FOUNTAIN SYNDROME	0.002172739	0.08151280274267067
CHIME SYNDROME	0.002172739	0.08151280274267067
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.08151280274267067
CHROMOSOME 18Q DELETION SYNDROME	0.002172739	0.08151280274267067
OHDO SYNDROME	0.002172739	0.08151280274267067
OROFACIODIGITAL SYNDROME I; OFD1	0.002172739	0.08151280274267067
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002172739	0.08151280274267067
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002172739	0.08151280274267067
RENPENNING SYNDROME 1; RENS1	0.002172739	0.08151280274267067
ZELLWEGER SYNDROME	0.002172739	0.08151280274267067
20Q13.33 MICRODELETION SYNDROME	0.002172739	0.08151280274267067
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.08151280274267067
MARDEN-WALKER SYNDROME	0.002172739	0.08151280274267067
RENPENNING SYNDROME	0.002172739	0.08151280274267067
KNOBLOCH SYNDROME	0.002172739	0.08151280274267067
SAETHRE-CHOTZEN SYNDROME	0.002172739	0.08151280274267067
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.002172739	0.08151280274267067
WOLCOTT-RALLISON SYNDROME	0.002172739	0.08151280274267067
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002172739	0.08151280274267067
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002172739	0.08151280274267067
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002172739	0.08151280274267067
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002172739	0.08151280274267067
TETRASOMY 18P	0.002172739	0.08151280274267067
DUBOWITZ SYNDROME	0.002172739	0.08151280274267067
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.08151280274267067
DISTAL MONOSOMY 3P	0.002172739	0.08151280274267067
ACROCALLOSAL SYNDROME; ACLS	0.002172739	0.08151280274267067
POTOCKI-SHAFFER SYNDROME	0.002172739	0.08151280274267067
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.08151280274267067
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.002172739	0.08151280274267067
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002172739	0.08151280274267067
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002172739	0.08151280274267067
HALL-RIGGS SYNDROME	0.002172739	0.08151280274267067
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.002172739	0.08151280274267067
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.08151280274267067
COFFIN-LOWRY SYNDROME	0.002172739	0.08151280274267067
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.08151280274267067
NON-DISTAL MONOSOMY 20Q	0.002172739	0.08151280274267067
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002172739	0.08151280274267067
ZUNICH NEUROECTODERMAL SYNDROME	0.002172739	0.08151280274267067
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.002172739	0.08151280274267067
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.002172739	0.08151280274267067
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.002172739	0.08151280274267067
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.08151280274267067
HENNEKAM SYNDROME	0.002172739	0.08151280274267067
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.08151280274267067
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002172739	0.08151280274267067
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.08138003308699351
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.08138003308699351
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.08138003308699351
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.08138003308699351
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.08138003308699351
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
CHARGE SYNDROME	0.0021691999999999996	0.08138003308699351
CHOANAL ATRESIA	0.0021691999999999996	0.08138003308699351
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.08138003308699351
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.08138003308699351
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 5; MGORS5	0.0021691999999999996	0.08138003308699351
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.08138003308699351
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0021691999999999996	0.08138003308699351
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.08138003308699351
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.08138003308699351
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.08138003308699351
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.08138003308699351
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.08138003308699351
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.08138003308699351
LOCKED-IN SYNDROME	0.0021691999999999996	0.08138003308699351
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.0021691999999999996	0.08138003308699351
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.08138003308699351
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.08138003308699351
ISOTRETINOIN-LIKE SYNDROME	0.0021691999999999996	0.08138003308699351
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.08138003308699351
SANDIFER SYNDROME	0.0021691999999999996	0.08138003308699351
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.08138003308699351
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699351
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.08138003308699351
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.08138003308699351
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.08138003308699351
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.08138003308699351
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.08138003308699351
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.08138003308699351
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.08138003308699351
INFANTILE SYSTEMIC HYALINOSIS	0.0021691999999999996	0.08138003308699351
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.08138003308699351
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.08138003308699351
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.08138003308699351
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0021691999999999996	0.08138003308699351
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.08138003308699351
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.08138003308699351
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699351
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.08138003308699351
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.08138003308699351
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.08138003308699351
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.08138003308699351
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.08138003308699351
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.08138003308699351
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.08138003308699351
CRISS-CROSS HEART	0.0021691999999999996	0.08138003308699351
MEIER-GORLIN SYNDROME 6; MGORS6	0.0021691999999999996	0.08138003308699351
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.08138003308699351
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.08138003308699351
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.08138003308699351
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.08138003308699351
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.08138003308699351
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.08138003308699351
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07588219133484224
BARDET-BIEDL SYNDROME 1; BBS1	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07588219133484224
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07588219133484224
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07588219133484224
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07588219133484224
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07588219133484224
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0020226539999999996	0.07588219133484224
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 6	0.0020226539999999996	0.07588219133484224
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0020226539999999996	0.07588219133484224
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 25	0.0020226539999999996	0.07588219133484224
WAARDENBURG-SHAH SYNDROME	0.0020226539999999996	0.07588219133484224
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0020226539999999996	0.07588219133484224
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0020226539999999996	0.07588219133484224
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0020226539999999996	0.07588219133484224
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0020226539999999996	0.07588219133484224
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 21	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 2	0.0020226539999999996	0.07588219133484224
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0020226539999999996	0.07588219133484224
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0020226539999999996	0.07588219133484224
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07588219133484224
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0020226539999999996	0.07588219133484224
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0020226539999999996	0.07588219133484224
IMMUNODEFICIENCY 23; IMD23	0.0020226539999999996	0.07588219133484224
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07588219133484224
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07588219133484224
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0020226539999999996	0.07588219133484224
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07588219133484224
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07588219133484224
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07588219133484224
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0020226539999999996	0.07588219133484224
HOYERAAL-HREIDARSSON SYNDROME	0.0020226539999999996	0.07588219133484224
SENIOR-LOKEN SYNDROME	0.0020226539999999996	0.07588219133484224
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0020226539999999996	0.07588219133484224
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07588219133484224
NAVAJO NEUROHEPATOPATHY	0.0020226539999999996	0.07588219133484224
MARINESCO-SJOGREN SYNDROME; MSS	0.0020226539999999996	0.07588219133484224
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0020226539999999996	0.07588219133484224
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0020226539999999996	0.07588219133484224
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0020226539999999996	0.07588219133484224
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 15	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07588219133484224
ARIMA SYNDROME	0.0020226539999999996	0.07588219133484224
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07588219133484224
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07588219133484224
PEROXISOME BIOGENESIS DISORDER 6B	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 8	0.0020226539999999996	0.07588219133484224
MARINESCO-SJÃ–GREN SYNDROME	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 28	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 27	0.0020226539999999996	0.07588219133484224
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07588219133484224
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07588219133484224
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07588219133484224
YOU-HOOVER-FONG SYNDROME; YHFS	0.0020226539999999996	0.07588219133484224
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0020226539999999996	0.07588219133484224
JOUBERT SYNDROME 7	0.0020226539999999996	0.07588219133484224
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07588219133484224
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07588219133484224
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.0757270620536258
FLYNN-AIRD SYNDROME	0.002018519	0.0757270620536258
XERODERMA PIGMENTOSUM	0.002018519	0.0757270620536258
EPISODIC ATAXIA TYPE 6	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.0757270620536258
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.0757270620536258
FAMILIAL DYSAUTONOMIA	0.002018519	0.0757270620536258
DYSEQUILIBRIUM SYNDROME	0.002018519	0.0757270620536258
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.0757270620536258
COG8-CDG	0.002018519	0.0757270620536258
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.002018519	0.0757270620536258
TYROSINEMIA TYPE 2	0.002018519	0.0757270620536258
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.0757270620536258
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.0757270620536258
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.0757270620536258
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.002018519	0.0757270620536258
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002018519	0.0757270620536258
RETT SYNDROME	0.002018519	0.0757270620536258
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.0757270620536258
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.0757270620536258
CAMOS SYNDROME	0.002018519	0.0757270620536258
ATAXIA-TELANGIECTASIA	0.002018519	0.0757270620536258
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.002018519	0.0757270620536258
KALLMANN SYNDROME	0.002018519	0.0757270620536258
SIALIDOSIS TYPE 1	0.002018519	0.0757270620536258
LEIGH SYNDROME	0.002018519	0.0757270620536258
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002018519	0.0757270620536258
ETHYLMALONIC ENCEPHALOPATHY	0.002018519	0.0757270620536258
SANDHOFF DISEASE	0.002018519	0.0757270620536258
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.0757270620536258
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002018519	0.0757270620536258
CONGENITAL MYASTHENIC SYNDROME	0.002018519	0.0757270620536258
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.002018519	0.0757270620536258
NEUROFIBROMATOSIS TYPE 1	0.002018519	0.0757270620536258
LHERMITTE-DUCLOS DISEASE	0.002018519	0.0757270620536258
DILATED CARDIOMYOPATHY WITH ATAXIA	0.002018519	0.0757270620536258
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.0757270620536258
ANGELMAN SYNDROME	0.002018519	0.0757270620536258
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002018519	0.0757270620536258
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.0757270620536258
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.0757270620536258
PGM3-CDG	0.002018519	0.0757270620536258
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.002018519	0.0757270620536258
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.0757270620536258
WHIPPLE DISEASE	0.002018519	0.0757270620536258
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.002018519	0.0757270620536258
GM1 GANGLIOSIDOSIS	0.002018519	0.0757270620536258
TRIPLE A SYNDROME	0.002018519	0.0757270620536258
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.0757270620536258
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.0757270620536258
ISOLATED CEREBELLAR AGENESIS	0.002018519	0.0757270620536258
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.0757270620536258
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.0757270620536258
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.002018519	0.0757270620536258
BETA-KETOTHIOLASE DEFICIENCY	0.002018519	0.0757270620536258
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.0757270620536258
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.0757270620536258
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.002018519	0.0757270620536258
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.0757270620536258
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.0757270620536258
BEHÃ‡ET DISEASE	0.002018519	0.0757270620536258
HEREDITARY HYPEREKPLEXIA	0.002018519	0.0757270620536258
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.002018519	0.0757270620536258
KUFOR-RAKEB SYNDROME	0.002018519	0.0757270620536258
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.002018519	0.0757270620536258
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002018519	0.0757270620536258
LISSENCEPHALY 3; LIS3	0.002018519	0.0757270620536258
DIAMINOPENTANURIA	0.002018519	0.0757270620536258
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.0757270620536258
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.0757270620536258
METACHROMATIC LEUKODYSTROPHY	0.002018519	0.0757270620536258
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.0757270620536258
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.0757270620536258
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.0757270620536258
MAPLE SYRUP URINE DISEASE; MSUD	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.002018519	0.0757270620536258
FLYNN-AIRD SYNDROME	0.002018519	0.0757270620536258
ALEXANDER DISEASE	0.002018519	0.0757270620536258
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.0757270620536258
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.002018519	0.0757270620536258
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002018519	0.0757270620536258
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.0757270620536258
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.0757270620536258
CYCLIC VOMITING SYNDROME	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.0757270620536258
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.0757270620536258
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.0757270620536258
THYROCEREBRORETINAL SYNDROME	0.002018519	0.0757270620536258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.0757270620536258
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.0757270620536258
COCKAYNE SYNDROME A; CSA	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.0757270620536258
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.0757270620536258
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.0757270620536258
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.0757270620536258
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.0757270620536258
BANGSTAD SYNDROME	0.002018519	0.0757270620536258
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.002018519	0.0757270620536258
PELIZAEUS-MERZBACHER DISEASE	0.002018519	0.0757270620536258
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.0757270620536258
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.0757270620536258
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.0757270620536258
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.002018519	0.0757270620536258
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.06120084619927821
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.06120084619927821
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.06120084619927821
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06120084619927821
CRANIOFACIAL DYSSYNOSTOSIS	0.00163132	0.06120084619927821
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.06120084619927821
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.06120084619927821
CEREBROOCULONASAL SYNDROME	0.00163132	0.06120084619927821
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06120084619927821
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00163132	0.06120084619927821
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.06120084619927821
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.06120084619927821
PENOSCROTAL TRANSPOSITION	0.00163132	0.06120084619927821
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06120084619927821
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06120084619927821
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.06120084619927821
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.06120084619927821
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.06120084619927821
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.06120084619927821
MONOSOMY 13Q14	0.00163132	0.06120084619927821
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.06120084619927821
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06120084619927821
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06120084619927821
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.06120084619927821
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00163132	0.06120084619927821
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.06120084619927821
NOONAN SYNDROME 4; NS4	0.00163132	0.06120084619927821
FEINGOLD SYNDROME 1; FGLDS1	0.00163132	0.06120084619927821
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06120084619927821
PHAVER SYNDROME	0.00163132	0.06120084619927821
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06120084619927821
OROFACIAL CLEFT 15	0.00163132	0.06120084619927821
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.06120084619927821
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06120084619927821
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06120084619927821
CLASSICAL EHLERS-DANLOS SYNDROME	0.00163132	0.06120084619927821
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06120084619927821
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00163132	0.06120084619927821
KEIPERT SYNDROME	0.00163132	0.06120084619927821
NOONAN SYNDROME 8; NS8	0.00163132	0.06120084619927821
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06120084619927821
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.06120084619927821
MILROY DISEASE	0.00163132	0.06120084619927821
FETAL VALPROATE SYNDROME	0.00163132	0.06120084619927821
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06120084619927821
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06120084619927821
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06120084619927821
TURNER SYNDROME	0.00163132	0.06120084619927821
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.06120084619927821
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.06120084619927821
RING CHROMOSOME 8 SYNDROME	0.00163132	0.06120084619927821
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00163132	0.06120084619927821
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06120084619927821
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.06120084619927821
CAREY-FINEMAN-ZITER SYNDROME	0.00163132	0.06120084619927821
TRISOMY XQ28	0.00163132	0.06120084619927821
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06120084619927821
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.06120084619927821
CARTILAGE-HAIR HYPOPLASIA	0.00163132	0.06120084619927821
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06120084619927821
DUBOWITZ SYNDROME	0.00163132	0.06120084619927821
RING CHROMOSOME 7 SYNDROME	0.00163132	0.06120084619927821
RING CHROMOSOME 6 SYNDROME	0.00163132	0.06120084619927821
GORLIN SYNDROME	0.00163132	0.06120084619927821
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06120084619927821
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.06120084619927821
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06120084619927821
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.06120084619927821
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06120084619927821
LEGIUS SYNDROME	0.00163132	0.06120084619927821
FRONTORHINY	0.00163132	0.06120084619927821
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.06120084619927821
TRISOMY 20P	0.00163132	0.06120084619927821
ACRORENAL-MANDIBULAR SYNDROME	0.00163132	0.06120084619927821
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06120084619927821
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.06120084619927821
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.06120084619927821
49,XXXYY SYNDROME	0.00163132	0.06120084619927821
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.06120084619927821
DOWN SYNDROME	0.00163132	0.06120084619927821
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.06120084619927821
RENAL AGENESIS, BILATERAL	0.00163132	0.06120084619927821
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.06120084619927821
MARTSOLF SYNDROME	0.00163132	0.06120084619927821
BALLER-GEROLD SYNDROME	0.00163132	0.06120084619927821
STICKLER SYNDROME	0.00163132	0.06120084619927821
MONOSOMY 5P	0.00163132	0.06120084619927821
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00163132	0.06120084619927821
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.06120084619927821
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.06120084619927821
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06120084619927821
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.06120084619927821
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.06120084619927821
3Q13 MICRODELETION SYNDROME	0.00163132	0.06120084619927821
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00163132	0.06120084619927821
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06120084619927821
14Q11.2 MICRODELETION SYNDROME	0.00163132	0.06120084619927821
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00163132	0.06120084619927821
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06120084619927821
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.06120084619927821
BRITTLE CORNEA SYNDROME	0.00163132	0.06120084619927821
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.06120084619927821
9P13 MICRODELETION SYNDROME	0.00163132	0.06120084619927821
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.06120084619927821
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06120084619927821
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.06120084619927821
MEGAEPIPHYSEAL DWARFISM	0.00163132	0.06120084619927821
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.06120084619927821
CEREBROOCULONASAL SYNDROME	0.00163132	0.06120084619927821
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.06120084619927821
EPICANTHUS	0.00163132	0.06120084619927821
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00163132	0.06120084619927821
RING CHROMOSOME 13 SYNDROME	0.00163132	0.06120084619927821
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.06120084619927821
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06120084619927821
ATELOSTEOGENESIS TYPE II	0.00163132	0.06120084619927821
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06120084619927821
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.06120084619927821
MONOSOMY X	0.00163132	0.06120084619927821
MOSAIC MONOSOMY X	0.00163132	0.06120084619927821
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06120084619927821
LICHTENSTEIN SYNDROME	0.00163132	0.06120084619927821
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.06120084619927821
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.06120084619927821
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00163132	0.06120084619927821
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.06120084619927821
COSTELLO SYNDROME	0.00163132	0.06120084619927821
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.06120084619927821
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.06120084619927821
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06120084619927821
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00163132	0.06120084619927821
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.06120084619927821
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06120084619927821
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00163132	0.06120084619927821
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06120084619927821
SCARF SYNDROME	0.00163132	0.06120084619927821
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.06120084619927821
BRADDOCK SYNDROME	0.00163132	0.06120084619927821
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.06120084619927821
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.06120084619927821
16P12.1P12.3 TRIPLICATION SYNDROME	0.00163132	0.06120084619927821
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.06120084619927821
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.06120084619927821
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.06120084619927821
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.06120084619927821
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00163132	0.06120084619927821
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.06120084619927821
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.06120084619927821
CRI-DU-CHAT SYNDROME	0.00163132	0.06120084619927821
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06120084619927821
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06120084619927821
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.06120084619927821
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06120084619927821
MONOSOMY 22	0.00163132	0.06120084619927821
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.06120084619927821
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.06120084619927821
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00163132	0.06120084619927821
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.06120084619927821
MOEBIUS SYNDROME	0.00163132	0.06120084619927821
MYOTONIA PERMANENS	0.00163132	0.06120084619927821
ACRODYSOSTOSIS	0.00163132	0.06120084619927821
MUCOLIPIDOSIS TYPE II	0.00163132	0.06120084619927821
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.06120084619927821
GMS SYNDROME	0.00163132	0.06120084619927821
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.06120084619927821
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.06120084619927821
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06120084619927821
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06120084619927821
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.06120084619927821
SCARF SYNDROME	0.00163132	0.06120084619927821
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.06120084619927821
SUMMITT SYNDROME	0.00163132	0.06120084619927821
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06120084619927821
OMODYSPLASIA 1; OMOD1	0.00163132	0.06120084619927821
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06120084619927821
JUBERG-MARSIDI SYNDROME	0.00163132	0.06120084619927821
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.06120084619927821
6P22 MICRODELETION SYNDROME	0.00163132	0.06120084619927821
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.06120084619927821
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.06120084619927821
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.06120084619927821
JACOBSEN SYNDROME	0.00163132	0.06120084619927821
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.06120084619927821
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.06120084619927821
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06120084619927821
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.06120084619927821
DISTAL TRISOMY 5Q	0.00163132	0.06120084619927821
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06120084619927821
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06120084619927821
SILLENCE SYNDROME	0.00163132	0.06120084619927821
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.06120084619927821
ACROOTOOCULAR SYNDROME	0.00163132	0.06120084619927821
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00163132	0.06120084619927821
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
EPISODIC ATAXIA, TYPE 8	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 3	0.0014770999999999999	0.05541510551023333
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.05541510551023333
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA	0.0014770999999999999	0.05541510551023333
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.05541510551023333
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.05541510551023333
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0014770999999999999	0.05541510551023333
BOUCHER-NEUHAUSER SYNDROME	0.0014770999999999999	0.05541510551023333
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.05541510551023333
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.05541510551023333
USHER SYNDROME TYPE 2	0.0014770999999999999	0.05541510551023333
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.05541510551023333
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.05541510551023333
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.05541510551023333
PENDRED SYNDROME	0.0014770999999999999	0.05541510551023333
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.05541510551023333
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.05541510551023333
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.05541510551023333
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.05541510551023333
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0014770999999999999	0.05541510551023333
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.05541510551023333
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0014770999999999999	0.05541510551023333
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.05541510551023333
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.05541510551023333
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.05541510551023333
MUCOLIPIDOSIS TYPE IV	0.0014770999999999999	0.05541510551023333
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.05541510551023333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.05541510551023333
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.05541510551023333
ALLAN-HERNDON-DUDLEY SYNDROME	0.0014770999999999999	0.05541510551023333
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.05541510551023333
245800 LAURENCE-MOON SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.05541510551023333
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.05541510551023333
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.05541510551023333
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.05541510551023333
KEARNS-SAYRE SYNDROME	0.0014770999999999999	0.05541510551023333
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.05541510551023333
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.05541510551023333
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.05541510551023333
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.05541510551023333
GEMIGNANI SYNDROME	0.0014770999999999999	0.05541510551023333
REFSUM DISEASE	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.05541510551023333
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.05541510551023333
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0014770999999999999	0.05541510551023333
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.05541510551023333
LEGIONELLOSIS	0.0014770999999999999	0.05541510551023333
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.05541510551023333
SANDHOFF DISEASE	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.05541510551023333
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.05541510551023333
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.05541510551023333
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.05541510551023333
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.05541510551023333
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.05541510551023333
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.0014770999999999999	0.05541510551023333
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.05541510551023333
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.05541510551023333
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.05541510551023333
USHER SYNDROME	0.0014770999999999999	0.05541510551023333
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0014770999999999999	0.05541510551023333
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
PITUITARY CARCINOMA	0.0014770999999999999	0.05541510551023333
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.05541510551023333
AGEL AMYLOIDOSIS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.05541510551023333
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.05541510551023333
ATAXIA-PANCYTOPENIA SYNDROME	0.0014770999999999999	0.05541510551023333
WALDENSTRÃ–M MACROGLOBULINEMIA	0.0014770999999999999	0.05541510551023333
CAMURATI-ENGELMANN DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.05541510551023333
HODGKIN LYMPHOMA	0.0014770999999999999	0.05541510551023333
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.05541510551023333
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.05541510551023333
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.05541510551023333
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.05541510551023333
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.05541510551023333
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.05541510551023333
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.05541510551023333
PIEBALDISM	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.05541510551023333
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.05541510551023333
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.05541510551023333
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.05541510551023333
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.05541510551023333
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.05541510551023333
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.05541510551023333
VON HIPPEL-LINDAU DISEASE	0.0014770999999999999	0.05541510551023333
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.05541510551023333
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.05541510551023333
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.05541510551023333
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.05541510551023333
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.05541510551023333
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.05541510551023333
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.05541510551023333
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.05541510551023333
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.05541510551023333
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.05541510551023333
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.05541510551023333
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
CHAND SYNDROME	0.0014770999999999999	0.05541510551023333
MACHADO-JOSEPH DISEASE; MJD	0.0014770999999999999	0.05541510551023333
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.05541510551023333
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 5	0.0014770999999999999	0.05541510551023333
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.05541510551023333
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.05541510551023333
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.05541510551023333
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.05541510551023333
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.05541510551023333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0014770999999999999	0.05541510551023333
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.05541510551023333
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.05541510551023333
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0014770999999999999	0.05541510551023333
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0014770999999999999	0.05541510551023333
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0014770999999999999	0.05541510551023333
RAVINE SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.05541510551023333
GÃ“MEZ-LÃ“PEZ-HERNÃNDEZ SYNDROME	0.0014770999999999999	0.05541510551023333
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0014770999999999999	0.05541510551023333
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0014770999999999999	0.05541510551023333
STIMMLER SYNDROME	0.0014770999999999999	0.05541510551023333
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.05541510551023333
ERDHEIM-CHESTER DISEASE	0.0014770999999999999	0.05541510551023333
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.0014770999999999999	0.05541510551023333
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 31	0.0014770999999999999	0.05541510551023333
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.05541510551023333
ACERULOPLASMINEMIA	0.0014770999999999999	0.05541510551023333
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.05541510551023333
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.05541510551023333
JOUBERT SYNDROME 4	0.0014770999999999999	0.05541510551023333
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.05541510551023333
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.05541510551023333
MICRO SYNDROME	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
FUCOSIDOSIS	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
CODAS SYNDROME	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.040779042368001395
BAND HETEROTOPIA; BH	0.001086973	0.040779042368001395
INCONTINENTIA PIGMENTI	0.001086973	0.040779042368001395
PETERS-PLUS SYNDROME; PTRPLS	0.001086973	0.040779042368001395
MUENKE SYNDROME	0.001086973	0.040779042368001395
FILIPPI SYNDROME	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
DUANE RETRACTION SYNDROME	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.040779042368001395
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.040779042368001395
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 3	0.001086973	0.040779042368001395
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.001086973	0.040779042368001395
POTOCKI-LUPSKI SYNDROME	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040779042368001395
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040779042368001395
PETTIGREW SYNDROME	0.001086973	0.040779042368001395
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.040779042368001395
TARP SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040779042368001395
PHACE SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
15Q14 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.040779042368001395
SCHINDLER DISEASE, TYPE I	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.040779042368001395
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040779042368001395
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
RECOMBINANT 8 SYNDROME	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
DIGEORGE SYNDROME; DGS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.040779042368001395
CONGENITAL TOXOPLASMOSIS	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
6Q TERMINAL DELETION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
DISTAL MONOSOMY 15Q	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
KABUKI SYNDROME 1	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040779042368001395
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.040779042368001395
KBG SYNDROME	0.001086973	0.040779042368001395
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.040779042368001395
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040779042368001395
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 1; CSS1	0.001086973	0.040779042368001395
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.040779042368001395
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.040779042368001395
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040779042368001395
DISTAL MONOSOMY 19P13.3	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.040779042368001395
COHEN SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
MACDERMOT-WINTER SYNDROME	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.040779042368001395
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 1; AOS1	0.001086973	0.040779042368001395
2Q37 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
JABERI-ELAHI SYNDROME; JABELS	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
16P13.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
PRADER-WILLI SYNDROME; PWS	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001086973	0.040779042368001395
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001086973	0.040779042368001395
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.040779042368001395
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.040779042368001395
CRANIOPHARYNGIOMA	0.001086973	0.040779042368001395
DONNAI-BARROW SYNDROME	0.001086973	0.040779042368001395
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.040779042368001395
WALKER-WARBURG SYNDROME	0.001086973	0.040779042368001395
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
OPTIC PATHWAY GLIOMA	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.040779042368001395
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.040779042368001395
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.040779042368001395
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.02046708582460892
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02046708582460892
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02046708582460892
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02046708582460892
TARP SYNDROME; TARPS	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02046708582460892
OROTIC ACIDURIA	0.000545554	0.02046708582460892
EPIDERMAL NEVUS SYNDROME	0.000545554	0.02046708582460892
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.02046708582460892
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02046708582460892
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02046708582460892
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02046708582460892
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02046708582460892
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02046708582460892
ABETAL34V AMYLOIDOSIS	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02046708582460892
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02046708582460892
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02046708582460892
MOSAIC TRISOMY 9	0.000545554	0.02046708582460892
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02046708582460892
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
12Q14 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
3Q29 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
CURRY-JONES SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02046708582460892
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02046708582460892
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02046708582460892
RIGID SPINE SYNDROME	0.000545554	0.02046708582460892
ZEBRA BODY MYOPATHY	0.000545554	0.02046708582460892
ISOLATED PLAGIOCEPHALY	0.000545554	0.02046708582460892
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02046708582460892
YUNIS-VARON SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.02046708582460892
WEAVER SYNDROME	0.000545554	0.02046708582460892
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.02046708582460892
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02046708582460892
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.02046708582460892
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.02046708582460892
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02046708582460892
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02046708582460892
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.02046708582460892
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02046708582460892
FARBER DISEASE	0.000545554	0.02046708582460892
LOWRY-MACLEAN SYNDROME	0.000545554	0.02046708582460892
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02046708582460892
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02046708582460892
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02046708582460892
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02046708582460892
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02046708582460892
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02046708582460892
ALPHA-MANNOSIDOSIS	0.000545554	0.02046708582460892
MEDULLOBLASTOMA	0.000545554	0.02046708582460892
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02046708582460892
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02046708582460892
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02046708582460892
3C SYNDROME	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02046708582460892
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02046708582460892
PETERS PLUS SYNDROME	0.000545554	0.02046708582460892
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.02046708582460892
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02046708582460892
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02046708582460892
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02046708582460892
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02046708582460892
ATELOSTEOGENESIS TYPE III	0.000545554	0.02046708582460892
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02046708582460892
RABSON-MENDENHALL SYNDROME	0.000545554	0.02046708582460892
JAWAD SYNDROME	0.000545554	0.02046708582460892
RAINE SYNDROME	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02046708582460892
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02046708582460892
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02046708582460892
TRANSKETOLASE DEFICIENCY	0.000545554	0.02046708582460892
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02046708582460892
NETHERTON SYNDROME; NETH	0.000545554	0.02046708582460892
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02046708582460892
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02046708582460892
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02046708582460892
MUCOLIPIDOSIS IV; ML4	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02046708582460892
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02046708582460892
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02046708582460892
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02046708582460892
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.02046708582460892
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02046708582460892
3MC SYNDROME 2	0.000545554	0.02046708582460892
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02046708582460892
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02046708582460892
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02046708582460892
WOLMAN DISEASE	0.000545554	0.02046708582460892
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.02046708582460892
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02046708582460892
BRESEK SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02046708582460892
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
FRIED SYNDROME	0.000545554	0.02046708582460892
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.02046708582460892
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02046708582460892
TREACHER-COLLINS SYNDROME	0.000545554	0.02046708582460892
SEPTOOPTIC DYSPLASIA	0.000545554	0.02046708582460892
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.02046708582460892
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02046708582460892
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.02046708582460892
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.02046708582460892
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.02046708582460892
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CURRARINO SYNDROME	0.000545554	0.02046708582460892
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02046708582460892
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.02046708582460892
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02046708582460892
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02046708582460892
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02046708582460892
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.02046708582460892
ALG6-CDG	0.000545554	0.02046708582460892
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.02046708582460892
AUSTRALIA ANTIGEN	0.000545554	0.02046708582460892
SYNDROMIC DIARRHEA	0.000545554	0.02046708582460892
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02046708582460892
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02046708582460892
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.02046708582460892
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02046708582460892
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02046708582460892
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.02046708582460892
NOONAN SYNDROME 11; NS11	0.000545554	0.02046708582460892
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02046708582460892
STEEL SYNDROME; STLS	0.000545554	0.02046708582460892
TRISOMY 17P	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02046708582460892
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
SECKEL SYNDROME 9; SCKL9	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02046708582460892
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02046708582460892
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02046708582460892
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
PENTASOMY X	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02046708582460892
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
N SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.02046708582460892
ALAZAMI SYNDROME; ALAZS	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02046708582460892
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02046708582460892
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02046708582460892
TRANSALDOLASE DEFICIENCY	0.000545554	0.02046708582460892
ZECHI-CEIDE SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 26	0.000545554	0.02046708582460892
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02046708582460892
JOUBERT SYNDROME 24	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.02046708582460892
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02046708582460892
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
OGDEN SYNDROME	0.000545554	0.02046708582460892
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02046708582460892
GERMAN SYNDROME	0.000545554	0.02046708582460892
DEXTROCARDIA	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02046708582460892
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02046708582460892
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02046708582460892
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02046708582460892
FRIAS SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.02046708582460892
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02046708582460892
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02046708582460892
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02046708582460892
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02046708582460892
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.02046708582460892
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02046708582460892
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02046708582460892
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.02046708582460892
EVEN-PLUS SYNDROME	0.000545554	0.02046708582460892
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02046708582460892
OKAMOTO SYNDROME	0.000545554	0.02046708582460892
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02046708582460892
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.02046708582460892
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.02046708582460892
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.02046708582460892
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.02046708582460892
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02046708582460892
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02046708582460892
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02046708582460892
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02046708582460892
CHOPS SYNDROME; CHOPS	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02046708582460892
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.02046708582460892
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02046708582460892
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02046708582460892
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02046708582460892
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02046708582460892
AL-RAQAD SYNDROME; ARS	0.000545554	0.02046708582460892
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02046708582460892
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02046708582460892
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.02046708582460892
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02046708582460892
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02046708582460892
HOLOPROSENCEPHALY 11	0.000545554	0.02046708582460892
CINCA SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.02046708582460892
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02046708582460892
RING CHROMOSOME 12 SYNDROME	0.000545554	0.02046708582460892
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02046708582460892
TRISOMY 9P	0.000545554	0.02046708582460892
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02046708582460892
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02046708582460892
ROIFMAN SYNDROME; RFMN	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02046708582460892
HYPERTRICHOSIS CUBITI	0.000545554	0.02046708582460892
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02046708582460892
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02046708582460892
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02046708582460892
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.02046708582460892
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.02046708582460892
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02046708582460892
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.02046708582460892
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.02046708582460892
MIETENS SYNDROME	0.000545554	0.02046708582460892
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02046708582460892
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02046708582460892
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02046708582460892
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02046708582460892
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02046708582460892
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.02046708582460892
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02046708582460892
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02046708582460892
NOONAN SYNDROME 9; NS9	0.000545554	0.02046708582460892
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02046708582460892
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02046708582460892
LIG4 SYNDROME	0.000545554	0.02046708582460892
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02046708582460892
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.02046708582460892
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02046708582460892
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02046708582460892
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02046708582460892
HURLER SYNDROME	0.000545554	0.02046708582460892
TEMTAMY SYNDROME	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02046708582460892
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02046708582460892
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02046708582460892
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02046708582460892
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02046708582460892
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02046708582460892
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02046708582460892
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.02046708582460892
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02046708582460892
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02046708582460892
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02046708582460892
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02046708582460892
ROBERTS SYNDROME	0.000545554	0.02046708582460892
DISTAL TRISOMY 6P	0.000545554	0.02046708582460892
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02046708582460892
NOONAN SYNDROME 2; NS2	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02046708582460892
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02046708582460892
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02046708582460892
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02046708582460892
TRISOMY 8Q	0.000545554	0.02046708582460892
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.02046708582460892
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02046708582460892
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02046708582460892
RAHMAN SYNDROME	0.000545554	0.02046708582460892
DYSKERATOSIS CONGENITA	0.000545554	0.02046708582460892
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02046708582460892
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02046708582460892
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02046708582460892
SAY-BARBER-MILLER SYNDROME	0.000545554	0.02046708582460892
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.02046708582460892
DISTAL TRISOMY 18Q	0.000545554	0.02046708582460892
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02046708582460892
OCCIPITAL HORN SYNDROME	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02046708582460892
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02046708582460892
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02046708582460892
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02046708582460892
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02046708582460892
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.02046708582460892
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02046708582460892
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.02046708582460892
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.02046708582460892
ALAZAMI-YUAN SYNDROME	0.000545554	0.02046708582460892
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02046708582460892
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02046708582460892
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.02046708582460892
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02046708582460892
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02046708582460892
XIA-GIBBS SYNDROME	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02046708582460892
COLE-CARPENTER SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02046708582460892
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02046708582460892
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02046708582460892
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02046708582460892
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.02046708582460892
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02046708582460892
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02046708582460892
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02046708582460892
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02046708582460892
OPTIC ATROPHY 11; OPA11	0.000545554	0.02046708582460892
CDAGS SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.02046708582460892
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.02046708582460892
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.02046708582460892
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02046708582460892
CULLER-JONES SYNDROME; CJS	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02046708582460892
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
MEIER-GORLIN SYNDROME 7	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 2	0.000545554	0.02046708582460892
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.02046708582460892
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
PRADER-WILLI SYNDROME	0.000541419	0.020311956543392472
SCLERODERMA	0.000541419	0.020311956543392472
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
CRYPTOCOCCOSIS	0.000541419	0.020311956543392472
47,XYY SYNDROME	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392472
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392472
COFS SYNDROME	0.000541419	0.020311956543392472
FOUNTAIN SYNDROME	0.000541419	0.020311956543392472
SJÃ–GREN-LARSSON SYNDROME	0.000541419	0.020311956543392472
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392472
PROTEUS SYNDROME	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.020311956543392472
DISTAL MONOSOMY 7Q36	0.000541419	0.020311956543392472
ALG2-CDG	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
DPM1-CDG	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392472
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
COHEN SYNDROME	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392472
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392472
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.020311956543392472
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392472
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020311956543392472
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392472
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.020311956543392472
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392472
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
CROME SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392472
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392472
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392472
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392472
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392472
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392472
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
INSULINOMA	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392472
HADDAD SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
LASSA FEVER	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.020311956543392472
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392472
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392472
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.020311956543392472
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.000541419	0.020311956543392472
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392472
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.020311956543392472
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.020311956543392472
ENCEPHALITIS LETHARGICA	0.000541419	0.020311956543392472
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392472
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392472
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.000541419	0.020311956543392472
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392472
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392472
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392472
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392472
CADASIL	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392472
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392472
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MEHMO SYNDROME	0.000541419	0.020311956543392472
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
SNEDDON SYNDROME	0.000541419	0.020311956543392472
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392472
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.020311956543392472
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392472
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392472
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392472
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.020311956543392472
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392472
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392472
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.020311956543392472
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392472
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392472
FRYNS SYNDROME; FRNS	0.000541419	0.020311956543392472
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392472
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392472
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392472
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392472
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392472
KLEEFSTRA SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
HHHH SYNDROME	0.000541419	0.020311956543392472
XP22.13P22.2 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392472
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.020311956543392472
COFFIN-LOWRY SYNDROME; CLS	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392472
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.020311956543392472
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392472
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392472
FABRY DISEASE	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392472
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392472
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392472
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
MALAN OVERGROWTH SYNDROME	0.000541419	0.020311956543392472
COG5-CDG	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
21Q22.11Q22.12 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
20P13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
TAKAYASU ARTERITIS	0.000541419	0.020311956543392472
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392472
NOCARDIOSIS	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
MERCURY POISONING	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392472
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392472
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.020311956543392472
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392472
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
RIFT VALLEY FEVER	0.000541419	0.020311956543392472
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392472
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.020311956543392472
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
15Q OVERGROWTH SYNDROME	0.000541419	0.020311956543392472
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392472
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392472
GALACTOSIALIDOSIS	0.000541419	0.020311956543392472
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
CRONKHITE-CANADA SYNDROME	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
CONGENITAL RUBELLA SYNDROME	0.000541419	0.020311956543392472
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.020311956543392472
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392472
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392472
GLIOBLASTOMA	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392472
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392472
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
TRISOMY 13	0.000541419	0.020311956543392472
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392472
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392472
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392472
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392472
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.020311956543392472
PROLACTINOMA	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
LISSENCEPHALY 5; LIS5	0.000541419	0.020311956543392472
MENKES DISEASE	0.000541419	0.020311956543392472
HARROD SYNDROME	0.000541419	0.020311956543392472
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.020311956543392472
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392472
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392472
KRABBE DISEASE	0.000541419	0.020311956543392472
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.020311956543392472
HENNEKAM-BEEMER SYNDROME	0.000541419	0.020311956543392472
MYASTHENIA GRAVIS	0.000541419	0.020311956543392472
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.020311956543392472
WHIM SYNDROME	0.000541419	0.020311956543392472
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392472
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
CONGENITAL HYDROCEPHALUS	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392472
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392472
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392472
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.020311956543392472
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392472
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.020311956543392472
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
NEVUS COMEDONICUS SYNDROME	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
ACROCARDIOFACIAL SYNDROME	0.000541419	0.020311956543392472
NORRIE DISEASE	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
CORNELIA DE LANGE SYNDROME	0.000541419	0.020311956543392472
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.000541419	0.020311956543392472
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392472
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
FILIPPI SYNDROME; FLPIS	0.000541419	0.020311956543392472
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392472
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392472
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392472
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392472
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392472
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392472
JUVENILE HUNTINGTON DISEASE	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.020311956543392472
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.020311956543392472
ADRENOLEUKODYSTROPHY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
MOYNAHAN SYNDROME	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392472
MICROSPORIDIOSIS	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.020311956543392472
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.020311956543392472
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
SLC39A8-CDG	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.020311956543392472
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392472
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392472
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.020311956543392472
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392472
RAMON SYNDROME	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
LOWRY-MACLEAN SYNDROME	0.000541419	0.020311956543392472
4Q21 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
PHENYLKETONURIA	0.000541419	0.020311956543392472
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392472
PERRAULT SYNDROME 3	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392472
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.020311956543392472
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392472
